JP2004067549A - External preparation for skin - Google Patents
External preparation for skin Download PDFInfo
- Publication number
- JP2004067549A JP2004067549A JP2002226754A JP2002226754A JP2004067549A JP 2004067549 A JP2004067549 A JP 2004067549A JP 2002226754 A JP2002226754 A JP 2002226754A JP 2002226754 A JP2002226754 A JP 2002226754A JP 2004067549 A JP2004067549 A JP 2004067549A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- cattleya
- skin
- external preparation
- genus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 47
- 239000000284 extract Substances 0.000 claims abstract description 259
- 241001517197 Cattleya Species 0.000 claims abstract description 62
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 31
- 241000196324 Embryophyta Species 0.000 claims abstract description 14
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract description 14
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 14
- 230000002087 whitening effect Effects 0.000 claims description 35
- 241000550167 Cattleya violacea Species 0.000 claims description 31
- 241001269357 Cattleya elongata Species 0.000 claims description 24
- 239000003963 antioxidant agent Substances 0.000 claims description 20
- 230000003078 antioxidant effect Effects 0.000 claims description 19
- 239000012190 activator Substances 0.000 claims description 14
- 239000003112 inhibitor Substances 0.000 claims description 13
- 241000233855 Orchidaceae Species 0.000 claims description 12
- 241000550180 Cattleya labiata Species 0.000 claims description 8
- 241001269284 Cattleya trianae Species 0.000 claims description 4
- 241000550165 Cattleya walkeriana Species 0.000 claims description 4
- 241001269354 Cattleya bicolor Species 0.000 claims description 3
- 241001269349 Cattleya granulosa Species 0.000 claims description 3
- 241000254173 Coleoptera Species 0.000 claims description 3
- 241000550228 Cattleya araguaiensis Species 0.000 claims description 2
- 241001313827 Cattleya dowiana Species 0.000 claims description 2
- 241001269353 Cattleya kerrii Species 0.000 claims description 2
- 241001269316 Cattleya mendelii Species 0.000 claims description 2
- 241001269317 Cattleya mossiae Species 0.000 claims description 2
- 241001269321 Cattleya porphyroglossa Species 0.000 claims description 2
- 241000206288 Cattleya rex Species 0.000 claims description 2
- 241001269285 Cattleya velutina Species 0.000 claims description 2
- 241001269286 Cattleya warneri Species 0.000 claims description 2
- 241001362576 Eana Species 0.000 claims description 2
- 241000550226 Guarianthe aurantiaca Species 0.000 claims description 2
- 241001234889 Cattleya maxima Species 0.000 claims 2
- 241000550222 Cattleya aclandiae Species 0.000 claims 1
- 241001269351 Cattleya iricolor Species 0.000 claims 1
- 241001239687 Cattleya schroederae Species 0.000 claims 1
- 241000292368 Cystoseira granulata Species 0.000 claims 1
- 241001595785 Granata Species 0.000 claims 1
- 241000550177 Guarianthe skinneri Species 0.000 claims 1
- -1 lipid peroxide Chemical class 0.000 abstract description 32
- 238000004519 manufacturing process Methods 0.000 abstract description 21
- 230000003405 preventing effect Effects 0.000 abstract description 19
- 239000004615 ingredient Substances 0.000 abstract description 15
- 230000032683 aging Effects 0.000 abstract description 11
- 230000002401 inhibitory effect Effects 0.000 abstract description 10
- 239000007844 bleaching agent Substances 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000007721 medicinal effect Effects 0.000 abstract description 4
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 3
- 229920000877 Melamine resin Polymers 0.000 abstract 1
- 238000004061 bleaching Methods 0.000 abstract 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 99
- 235000019441 ethanol Nutrition 0.000 description 53
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 230000000694 effects Effects 0.000 description 31
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 28
- 239000008213 purified water Substances 0.000 description 25
- 230000009759 skin aging Effects 0.000 description 19
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 18
- 235000006708 antioxidants Nutrition 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- 239000000419 plant extract Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 239000006071 cream Substances 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- 239000003755 preservative agent Substances 0.000 description 14
- 230000002265 prevention Effects 0.000 description 14
- 230000002335 preservative effect Effects 0.000 description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 12
- 239000003205 fragrance Substances 0.000 description 12
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 11
- 241001268742 Cattleya purpurata Species 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 206010013786 Dry skin Diseases 0.000 description 10
- 230000006872 improvement Effects 0.000 description 10
- 208000003351 Melanosis Diseases 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000010419 fine particle Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000011787 zinc oxide Substances 0.000 description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- 206010014970 Ephelides Diseases 0.000 description 8
- 241000272185 Falco Species 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 238000013329 compounding Methods 0.000 description 7
- 239000000839 emulsion Substances 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 241001126925 Lobata Species 0.000 description 6
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 6
- 235000006468 Thea sinensis Nutrition 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 229960000541 cetyl alcohol Drugs 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000008099 melanin synthesis Effects 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- 229960000984 tocofersolan Drugs 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- 241001474374 Blennius Species 0.000 description 5
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 5
- 235000010099 Fagus sylvatica Nutrition 0.000 description 5
- 240000000731 Fagus sylvatica Species 0.000 description 5
- 235000011201 Ginkgo Nutrition 0.000 description 5
- 244000194101 Ginkgo biloba Species 0.000 description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 description 5
- 208000012641 Pigmentation disease Diseases 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 235000021466 carotenoid Nutrition 0.000 description 5
- 150000001747 carotenoids Chemical class 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 229940057995 liquid paraffin Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 230000019612 pigmentation Effects 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 5
- 239000009538 yokuinin Substances 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
- 208000001382 Experimental Melanoma Diseases 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 206010042496 Sunburn Diseases 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 230000003859 lipid peroxidation Effects 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 235000020712 soy bean extract Nutrition 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- DXANYXRZRNXGSC-UHFFFAOYSA-N 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl sulfate Chemical compound CC1=C(CCOS([O-])(=O)=O)SC=[N+]1CC1=CN=C(C)N=C1N DXANYXRZRNXGSC-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 235000009434 Actinidia chinensis Nutrition 0.000 description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 3
- 241000499950 Arthropodium cirratum Species 0.000 description 3
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 3
- 235000007319 Avena orientalis Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 241000550172 Cattleya mooreana Species 0.000 description 3
- 240000008067 Cucumis sativus Species 0.000 description 3
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 208000035874 Excoriation Diseases 0.000 description 3
- 108010024636 Glutathione Proteins 0.000 description 3
- 235000017309 Hypericum perforatum Nutrition 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- GZQCZDHGTYFJIF-LZWOXQAQSA-N [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] acetate Chemical compound CC(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O GZQCZDHGTYFJIF-LZWOXQAQSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000020279 black tea Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 229940008396 carrot extract Drugs 0.000 description 3
- 235000020221 chamomile extract Nutrition 0.000 description 3
- 229940119217 chamomile extract Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 229960002104 cyanocobalamin Drugs 0.000 description 3
- 235000000639 cyanocobalamin Nutrition 0.000 description 3
- 239000011666 cyanocobalamin Substances 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 3
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 3
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 3
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 3
- 235000019152 folic acid Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 235000020717 hawthorn extract Nutrition 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 235000020333 oolong tea Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 3
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 3
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 3
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 229940108325 retinyl palmitate Drugs 0.000 description 3
- 235000019172 retinyl palmitate Nutrition 0.000 description 3
- 239000011769 retinyl palmitate Substances 0.000 description 3
- 235000019192 riboflavin Nutrition 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 239000002151 riboflavin Substances 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 3
- 239000011747 thiamine hydrochloride Substances 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- CGFPNELNAZZYQL-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfuric acid Chemical compound OS(O)(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CGFPNELNAZZYQL-RXSVEWSESA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N (Z,Z,Z)-Octadeca-9,12,15-trienoic acid Natural products CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- QHNVWXUULMZJKD-UHFFFAOYSA-N 3,4-didehydroretinal Chemical compound O=CC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C QHNVWXUULMZJKD-UHFFFAOYSA-N 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 244000298697 Actinidia deliciosa Species 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 235000003826 Artemisia Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 244000003416 Asparagus officinalis Species 0.000 description 2
- 235000005340 Asparagus officinalis Nutrition 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 241001072256 Boraginaceae Species 0.000 description 2
- 235000007689 Borago officinalis Nutrition 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241001269288 Cattleyopsis Species 0.000 description 2
- 240000001980 Cucurbita pepo Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 241001071795 Gentiana Species 0.000 description 2
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 2
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 241000945534 Hamana Species 0.000 description 2
- 244000267823 Hydrangea macrophylla Species 0.000 description 2
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 244000141009 Hypericum perforatum Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 241000152982 Laelia <moth> Species 0.000 description 2
- 241001103596 Lelia Species 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- 240000000982 Malva neglecta Species 0.000 description 2
- 235000000060 Malva neglecta Nutrition 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001645024 Miconia chocoensis Species 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 241000183666 Nepsera aquatica Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 244000178231 Rosmarinus officinalis Species 0.000 description 2
- 241000220156 Saxifraga Species 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 240000002299 Symphytum officinale Species 0.000 description 2
- 235000005865 Symphytum officinale Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 240000000377 Tussilago farfara Species 0.000 description 2
- 235000004869 Tussilago farfara Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 244000274883 Urtica dioica Species 0.000 description 2
- 235000009108 Urtica dioica Nutrition 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 241001222097 Xenocypris argentea Species 0.000 description 2
- 241000269959 Xiphias gladius Species 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940089116 arnica extract Drugs 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 235000009052 artemisia Nutrition 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000004042 decolorization Methods 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940007062 eucalyptus extract Drugs 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 150000002224 folic acids Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229940002508 ginger extract Drugs 0.000 description 2
- 235000020708 ginger extract Nutrition 0.000 description 2
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 239000008169 grapeseed oil Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 2
- 229940069774 quince extract Drugs 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 235000021335 sword fish Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 241000219475 Bougainvillea Species 0.000 description 1
- 235000011960 Brassica ruvo Nutrition 0.000 description 1
- SNTZXERIMIDMEK-UHFFFAOYSA-N C(C1=CC=CC=C1)OC(C1=CN=CC=C1)=O.C(C1=CN=CC=C1)(=O)O Chemical compound C(C1=CC=CC=C1)OC(C1=CN=CC=C1)=O.C(C1=CN=CC=C1)(=O)O SNTZXERIMIDMEK-UHFFFAOYSA-N 0.000 description 1
- 241000219357 Cactaceae Species 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 241001440794 Caloplaca cinnabarina Species 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241001268616 Cattleya jongheana Species 0.000 description 1
- 241001268257 Cattleya lobata Species 0.000 description 1
- 241000587793 Cattleya lueddemanniana Species 0.000 description 1
- 241001517191 Cattleya tigrina Species 0.000 description 1
- 241000561734 Celosia cristata Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000013988 Colletes skinneri Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 239000006000 Garlic extract Substances 0.000 description 1
- 235000005491 Geranium thunbergii Nutrition 0.000 description 1
- 244000105059 Geranium thunbergii Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 240000005074 Hymenocallis caribaea Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 244000150775 Laelia perrinii Species 0.000 description 1
- 241000623365 Lagerstroemia hirsuta Species 0.000 description 1
- 244000056693 Lannea coromandelica Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000003488 Lavandula canariensis Species 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 244000059273 Licuala pumila Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000494585 Lilium rubescens Species 0.000 description 1
- 241000012828 Lindsaea crispa Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 240000003477 Loxanthera speciosa Species 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 241001491705 Macrocystis pyrifera Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 241000580955 Sapindus mukorossi Species 0.000 description 1
- 241000543810 Sasa veitchii Species 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000463686 Somatochlora tenebrosa Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241001092387 Spiraea Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241001261506 Undaria pinnatifida Species 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- GLLSGHWYBGERSE-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone;sodium Chemical compound [Na].OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 GLLSGHWYBGERSE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 235000020739 avocado extract Nutrition 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940107033 cayenne extract Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000001520 comb Anatomy 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- HRUVKSKSDDVGMC-JDYVBSGKSA-L disodium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfate Chemical compound [Na+].[Na+].OS([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] HRUVKSKSDDVGMC-JDYVBSGKSA-L 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 235000020706 garlic extract Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229940083980 lavender extract Drugs 0.000 description 1
- 235000020723 lavender extract Nutrition 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000008133 orange flower water Substances 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 244000034971 purple passionvine Species 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000020945 retinal Nutrition 0.000 description 1
- 239000011604 retinal Substances 0.000 description 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- KMPHTYSTEHXSTL-UHFFFAOYSA-M sodium;2-hydroxypropanoate;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O.CC(O)C([O-])=O KMPHTYSTEHXSTL-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- KJCLYACXIWMFCC-UHFFFAOYSA-M sodium;5-benzoyl-4-hydroxy-2-methoxybenzenesulfonate Chemical compound [Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 KJCLYACXIWMFCC-UHFFFAOYSA-M 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 150000003669 ubiquinones Chemical class 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】
【発明の属する技術分野】
本発明は、ラン科カトレア属(Cattleya)、ブラッソカトレア属(Brassocattleya)、ブラッソレリオカトレア属(Brassolaeliocattleya)、レリオカトレア属(Laeliocattleya)、レリオカトニア属(Laeliocatonia)、カトレイオプシス属(Cattleyopsis)、カトレイトニア属(Cattleytonia)、レリア(Laelia)属に属する植物抽出物を含有する皮膚外用剤に関し、更に詳細には、ラン科カトレア属、ブラッソカトレア属、ブラッソレリオカトレア属、レリオカトレア属、レリオカトニア属、カトレイオプシス属、カトレイトニア属、レリア属に属する植物抽出物を含有することにより、皮膚のくすみ、シミ、ソバカス又は老人性色素斑及び肝斑等の色素沈着の予防及び改善並びに肌の透明感を改善する美白効果に優れる皮膚外用剤に関する。また、皮膚内での活性酸素生成に起因する過酸化脂質の生成や、肌の炎症、黒化、老化を防止することにより皮膚老化防止効果、肌あれ改善効果を有する皮膚外用剤に関する。更に、これらの特定のラン科植物抽出物と他の薬効剤とを組み合わせることにより、上記効果がより一層高められた皮膚外用剤に関する。
【0002】
【従来の技術】
従来より、乳液、クリーム、化粧水、パック、洗浄料、分散液、軟膏、液剤、エアゾール、貼付剤、パップ剤、リニメント剤等の皮膚外用剤には、これらに所定の薬効を付与することを目的として種々の薬効剤が加えられている。
例えば、日焼け等により生じる皮膚の黒化、色素沈着により生ずるシミ、ソバカス等を予防又は改善する為に、アスコルビン酸、胎盤抽出物、グルタチオン、ハイドロキノン等の美白剤が加えられている。
【0003】
また、過酸化脂質の生成や肌の炎症、黒化、老化を防止することを目的として、ビタミンEなどの抗酸化剤が加えられている。
近年では、皮膚老化の原因の一つとして、生体に対する活性酸素の悪影響が挙げられている。活性酸素には、スーパーオキサイド、一重項酸素、ヒドロキシラジカル、過酸化水素等があるが、これらは過酸化脂質の生成や、核、タンパク質、酵素にダメージを与えることが分かっており、これらが大量に発生した場合には疾病や死を招くことがある。また、量的には少なくとも、活性酸素に起因するダメージの蓄積は生体機能を低下させ、いわゆる老化現象を引き起こす一因になっている。
このため、様々な活性酸素除去剤が開発されている。
【0004】
【発明が解決しようとする課題】
しかしながら、上記の薬効剤では、効果が十分でなかったり、あるいは、製剤中で変質する等して所期の薬効が得られない場合があり、その改善が望まれていた。
【0005】
【課題を解決するための手段】
本発明者らは、皮膚外用剤の薬効成分として使用することができる成分について鋭意検討を行った結果、ラン科カトレア属(Cattleya)、ブラッソカトレア属(Brassocattleya)、ブラッソレリオカトレア属(Brassolaeliocattleya)、レリオカトレア属(Laeliocattleya)、レリオカトニア属(Laeliocatonia)、カトレイオプシス属(Cattleyopsis)、カトレイトニア属(Cattleytonia)、レリア(Laelia)属(以下、前記属を総称してカトレア類と表記することがある)に属する植物抽出物が高いメラニン生成抑制作用及び抗酸化作用を有し、美白及び抗酸化成分として優れたものであることを見出した。そして、この抽出物は、美白成分及び/又は抗酸化成分として皮膚外用剤に配合できると共に、他の薬効剤と組み合わせることにより皮膚外用剤としてより優れた効果が得られることを見出し、本発明を完成した。
【0006】
すなわち本発明は、カトレア類に属する植物抽出物を美白成分及び/又は抗酸化成分として含有することを特徴とする、優れた美白効果を有し、くすみ、シミ、ソバカス又は老人性色素斑及び肝斑等の色素沈着の予防及び改善並びに肌の透明感を改善する皮膚外用剤を提供するものである。また、皮膚内での活性酸素生成に起因する過酸化脂質の生成や、肌の炎症、黒化、老化を防止することにより皮膚老化防止効果、肌あれ改善効果を有する皮膚外用剤を提供するものである。
【0007】
又、本発明は、カトレア類の植物の抽出物、および美白剤、抗酸化剤、抗炎症剤、細胞賦活剤及び紫外線防止剤から選ばれる薬効剤の一種又は二種以上、を含有することを特徴とする皮膚外用剤を提供するものである。
【0008】
【発明の実施の形態】
本発明に用いられるカトレア類について述べるが、ラン科カトレア属に属する植物は、カトレアの原種であるといわれており、ランの女王とよばれるほど美しい花をつける。中央、南アメリカの熱帯に約30種が分布する着生ランで、近縁の属との交雑によって多くの交雑種が作り出され切花や鉢花用として広く栽培されている。カトレア属に属する植物としては、カトレア ビコロル(C.bicolor)、カトレア アクランディアエ(C.aclandiae)、カトレア アウランティアカ(C.aurantiaca)、カトレア ボーリンギアナ(C.bowringiana)、カトレアレオポルディー(C.leopoldii)、カトレア メンデリー(C.mendelii)、カトレア ポーフィログロッサ(C.porphyroglossa)、カトレア スキンネリ(C.skinneri)、カトレア ウオーケリアナ(C.walkeriana)、カトレア フォーブシー(C.forbesii)、カトレア ローレンセアナ(C.lawrenceana)、カトレアインテルメディア(C.intermedia)、カトレア ベルティナ(C.velutina)、カトレア ワーネリ(C.warneri)、カトレア エルドラド(C.eldorado)、カトレア モシアエ(C.mossiae)、カトレア ガスケリアナ(C.gaskelliana)、カトレア パーシヴァリアナ(C.percivalliana)、カトレア イヴァリアナ(C.ivaliana)、カトレア ルーデマニアナ(C.lueddemanniana)、カトレア ジェンマニー(C.jenmanii)、カトレア イアナ(C.eana)、カトレア トリアナエ(C.trianae)、カトレア チョコエンシス(C.chocoensis)、カトレア シュレーデラエ(C.schroederae)、カトレア ヴァルセヴィチー(C. warscewiczii)、カトレア ドーウィアナ(C.dowiana)、カトレア レックス(C.rex)、カトレア マクシマ(C.maxima)、カトレア オロル(C.olor)、カトレア ルテオラ(C.luteora)、カトレア ムーレアナ(C.mooreana)、カトレア ケリー(C.kerrii)、カトレア アラグアイエンシス(C.araguaiensis)、カトレアエロンガータ(C.elongata)、カトレア ビオラセア(C.violacea)、カトレア グラヌロサ(C.granulosa)、カトレア グッタタ(C.guttata)、カトレアイリコロル(C.iricolor)、カトレア ロディギシー(C.loddigesii)、カトレア シレリアナ(C.schilleriana)、カトレア ラビアタ(C.labiata)等が挙げられる。
【0009】
レリア属はカトレア属の近縁種でブラジルを中心とする中央、南アメリカの熱帯に約50種が分布するランで、レリア属にはレリア アルビダ(L.albida)、レリア アンセプス(L.anceps)、レリア オータムナリス(L.autumnalis)、レリア カナリエンシス(L.canariensis)、レリア シンアバリア(L.cinnabarina)、レリア クリスパ(L.crispa)、レリア エサルクエアナ(L.esalqueana)、レリア フルフラセア(L.furfuracea)、レリア グランディス(L.grandis)、レリア ジョンゲアナ(L.jongheana)、レリア ロバタ(L.lobata)、レリア ロンギピア(L.longipea)、レリア ルンディー(L.lundii)、レリアペリーニー(L.perrinii)、レリア プミラ(L.pumila)、レリア プルプラタ(L.purpurata)、レリア レジナエ(L.reginae)、レリア ルベセンス(L.rubescens)、レリア シンコラナ(L.sincorana)、レリア スペシオサ(L.speciosa)、レリア テネブロサ(L.tenebrosa)、レリア ジップ(L.zip)等が含まれる。
【0010】
カトレイオプシス属(Cattleyopsis)はカトレア属の近縁種で、西インド諸島に3種が分布する花の美しい着生あるいは岩上生のランである。カトレイオプシス属には、C.lindenii(カトレイオプシス リンデニー)等が含まれる。
【0011】
ブラッソカトレア属(Brassocattleya)、ブラッソレリオカトレア属(Brassolaeliocattleya)、レリオカトレア属(Laeliocattleya)、レリオカトニア属(Laeliocatonia)、カトレイトニア属(Cattleytonia)、レリオカトニア属(Laeliocatonia)は、カトレア属及びその近縁種との交配によりにできた人工種である。いずれも非常に多くの種類が存在し、カトレアやその近縁種の特徴を踏襲した、美しい花をつけるランである。
【0012】
上記のカトレア類の植物には、フェノール性化合物、カロチノイド、SOD、カタラーゼ、ビタミン等が豊富に含まれており、それらの成分が美白効果や抗酸化効果を複合的に発揮するものと考えられる。
【0013】
本発明に用いられる抽出物を製造するにあたっては、カトレア類の種類や産地は特に限定されない。また、抽出物の調製法は、特に限定されるものではないが、その例としては、全草、又は根、茎、幼芽、葉、花、種子等のいずれか1ヶ所以上から抽出することが出来、これらを乾燥、細切、圧搾、或いは発酵等、適宜処理を施した後、低温もしくは室温〜加温下で溶媒により抽出する方法を挙げることができる。得られた抽出液は、濾過又はイオン交換樹脂等を用い、吸着、脱色等の精製をして、溶液状、ペースト状、ゲル状、粉末状として用いることもできる。必要ならば、効果に影響のない範囲で更に、脱臭、脱色等の精製処理をしても良い。また、超臨界抽出や水蒸気蒸留による抽出も好適に用いられる。
【0014】
抽出溶媒としては、例えば水、低級1価アルコール(メチルアルコール、エチルアルコール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール(グリセリン、プロピレングリコール、1,3−ブチレングリコール等)、低級アルキルエステル(酢酸エチル等)、炭化水素(ベンゼン、ヘキサン、ペンタン等)、ケトン類(アセトン、メチルエチルケトン等)、エーテル類(ジエチルエーテル、テトラヒドロフラン、ジプロピルエーテル等)、アセトニトリル等が挙げられ、一種又は二種以上を用いることができる。
【0015】
又、好ましい抽出方法の例としては、濃度0〜100vol%の含水エチルアルコール又は1,3−ブチレングリコールを用い、室温で、又は加温して1〜5日間抽出を行った後濾過し、得られた濾液を更に1週間ほど放置して熟成させ、再び濾過を行う方法が挙げられる。
【0016】
本発明の皮膚外用剤におけるカトレア類の植物抽出物の含有量は、乾燥固形分として好ましくは0.00001〜5質量%(以下単に「%」で示す)であり、より好ましくは0.0001〜2%である。この範囲内であれば、該植物抽出物を安定に配合することができ、かつ高い美白及び抗酸化効果を発揮することができる。又、抽出液を使用する場合は、溶質である乾燥固形分の含有量が上記範囲内であれば、その抽出液濃度は何ら限定されるものではない。
【0017】
本発明のカトレア類の植物抽出物は、これを美白及び抗酸化成分として常法に従い、通常の皮膚外用剤に使用される種々の形態の基剤に配合し、製剤化することにより皮膚外用剤を得ることができるが、更に他の薬効剤と組み合せることにより、より美白及び抗酸化効果の優れた皮膚外用剤が得られる。
【0018】
本発明においてカトレア類の植物抽出物(成分(A))と組み合わせ、使用される他の薬効剤(成分(B))は、美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤から選ばれるものであるが、具体的な薬効剤としては、例えば、それぞれ以下に示すものが挙げられる。但し、複数の薬効を有するものは、該当する各薬効剤として重複して挙げている。ここで「誘導体」には形成可能なエステルや塩が含まれる。更にカッコ内は、植物の別名、生薬名等を記載した。
【0019】
(美白剤)
美白剤としては、ビタミンC及びその誘導体(ジパルミチン酸−L−アスコルビル、テトライソパルミチン酸−L−アスコルビル等のL−アスコルビン酸アルキルエステル、L−アスコルビン酸リン酸エステル、L−アスコルビン酸硫酸エステル等)、胎盤抽出物、グラブリジン、グラブレン、リクイリチン、イソリクイリチン及びこれらを含有するカンゾウ抽出物、ヨクイニン(ハトムギ)抽出物、コガネバナ(オウゴン)抽出物、海藻抽出物(コンブ、マコンブ、ワカメ、ヒジキ、ヒバマタ、スジメ、トロロコンブ、カジメ、ツルアラメ、チガイソ、ホンダワラ、ジャイアントケルプ等の褐藻類;テングサ、ツノマタ、スギノリ、ウスバノリ、アサクサノリ、マツノリ、トサカマツ、フノリ、オゴノリ、カイメンソウ、イギス、エゴノリ等の紅藻類;クロレラ、アオノリ、ドナリエラ、クロロコッカス、アナアオサ、カワノリ、マリモ、シオグサ、カサノリ、フトジュズモ、タマジュズモ、ヒトエグサ、アオミドロ等の緑藻類;スピルリナ等の藍藻類等)、センプクカ抽出物、ブドウ抽出物、コムギ抽出物、トマト抽出物、カロチノイド(カロチン、リコピン、アスタキサンチン等)、アガロース、オリゴサッカライド、ハイドロキノン及びその誘導体、システイン及びその誘導体、アスパラガス抽出物、イブキトラノオ抽出物、ノイバラ(エイジツ)抽出物、エゾウコギ抽出物、エンドウ豆抽出物、カミツレ抽出物、ケイケットウ抽出物、オレンジ抽出物、キイチゴ抽出物、キウイ抽出物、クララ(クジン)抽出物、コーヒー抽出物、ゴマ油、エゴマ油、ゴカヒ抽出物、コメ抽出物、コメヌカ抽出物、サイシン抽出物、サンザシ抽出物、サンペンズ(カワラケツメイ)抽出物、シャクヤク抽出物、シラユリ抽出物、クワ(ソウハクヒ)抽出物、トウキ抽出物、ブナノキ抽出物、ブナの芽抽出物、ブラックカラント抽出物、ホップ抽出物、マイカイカ(マイカイ、ハマナス)抽出物、モッカ(ボケ)抽出物、ユキノシタ抽出物、茶抽出物(烏龍茶、紅茶、緑茶等)、霊芝抽出物、微生物醗酵代謝産物、大豆抽出物、糖蜜抽出物、羅漢果抽出物等が挙げられる。
【0020】
これらの美白剤のうち、特に好ましいものとしては、ビタミンC及びその誘導体、カンゾウ抽出物、ハトムギ(ヨクイニン)抽出物、コムギ抽出物、クワ(ソウハクヒ)抽出物、海藻抽出物、茶抽出物が挙げられる。
【0021】
(抗酸化剤)
又、抗酸化剤としては、ビタミンE及びその誘導体(dl−α(β、γ)−トコフェロール、酢酸dl−α−トコフェロール、ニコチン酸dl−α−トコフェロール、リノール酸dl−α−トコフェロール、コハク酸dl−α−トコフェロール等のトコフェロール及びその誘導体、ユビキノン類等)、ビタミンA及びその誘導体(パルミチン酸レチノール、酢酸レチノール等のレチノール及びその誘導体、デヒドロレチナール等のレチナール及びその誘導体等)、カロチノイド(カロチン、リコピン、アスタキサンチン等)、クエルセチン、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、ビタミンB及びその誘導体(チアミン塩酸塩、チアミン硫酸塩、リボフラビン、酢酸リボフラビン、塩酸ピリドキシン、ピリドキシンジオクタノエート、フラビンアデニンジヌクレオチド、シアノコバラミン、葉酸類、ニコチン酸アミド、ニコチン酸ベンジル等のニコチン酸類、コリン類等)、ビタミンC.及びその誘導体(ジパルミチン酸−L−アスコルビルやテトライソパルミチン酸−L−アスコルビル等のL−アスコルビン酸アルキルエステル、L−アスコルビン酸リン酸エステル、L−アスコルビン酸硫酸エステル等)、ビタミンD及びその誘導体(エルゴカルシフェロール、コレカルシフェロール、ジヒドロキシスタナール等)、ルチン及びその誘導体、チオタウリン、タウリン、ハイドロキノン及びその誘導体、ヒスチジン、カテキン及びその誘導体、グラブリジン、グラブレン、リクイリチン、イソリクイリチン及びこれらを含有するカンゾウ抽出物、グルタチオン及びその誘導体、没食子酸及びその誘導体、キュウリ抽出物、ケイケットウ抽出物、ゲンチアナ(リンドウ)抽出物、ゲンノショウコ抽出物、コレステロール及びその誘導体、サンザシ抽出物、シャクヤク抽出物、スーパーオキサイドディスムターゼ、イチョウ抽出物、コガネバナ(オウゴン)抽出物、ニンジン抽出物、マイカイカ(マイカイ、ハマナス)抽出物、サンペンズ(カワラケツメイ)抽出物、トルメンチラ抽出物、パセリ抽出物、ブドウ抽出物、ボタン(ボタンピ)抽出物、マンニトール、モッカ(ボケ)抽出物、メリッサ抽出物、ヤシャジツ(ヤシャ)抽出物、ユキノシタ抽出物、ローズマリー(マンネンロウ)抽出物、レタス抽出物、茶抽出物(烏龍茶、紅茶、緑茶等)、微生物醗酵代謝産物、海藻抽出物、霊芝抽出物、卵殻膜抽出物、胎盤抽出物、羅漢果抽出物等が挙げられる。
【0022】
これらの抗酸化剤のうち、特に好ましいものとしては、ビタミンE及びその誘導体、ビタミンC.及びその誘導体、ルチン及びその誘導体、ヤシャジツ抽出物、ユキノシタ抽出物、マイカイカ抽出物、スーパーオキサイドディスムターゼ、イチョウ抽出物、グルタチオン及びその誘導体、ヒスチジン、マンニトール、カロチノイドが挙げられる。
【0023】
(抗炎症剤)
抗炎症剤としては、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、ビタミンB及びその誘導体(チアミン塩酸塩、チアミン硫酸塩、リボフラビン、酢酸リボフラビン、塩酸ピリドキシン、ピリドキシンジオクタノエート、フラビンアデニンジヌクレオチド、シアノコバラミン、葉酸類、ニコチン酸アミド、ニコチン酸ベンジル等のニコチン酸類、コリン類等)、アロエ抽出物、アシタバ抽出物、アルテア抽出物、アルニカ抽出物、イオウ及びその誘導体、イラクサ抽出物、インチンコウ(カワラヨモギ)抽出物、ウコン抽出物、キハダ(オウバク)抽出物、オトギリソウ抽出物、カミツレ抽出物、コンフリー(ヒレハリソウ)抽出物、スイカズラ(キンギンカ)抽出物、クレソン抽出物、サルビア(セージ)抽出物、ワレモコウ(ジユ)抽出物、シソ抽出物、シラカバ抽出物、ニワトコ抽出物、ガマ(ホオウ)抽出物、ムクロジ抽出物、ユーカリ抽出物、ヨモギ抽出物、レンゲソウ抽出物、コンドロイチン硫酸及びその誘導体、酸化亜鉛等が挙げられる。
【0024】
これらの抗炎症剤のうち、特に好ましいものとしては、グリチルリチン酸及びその誘導体、グリチルレチン酸及びその誘導体、コンフリー(ヒレハリソウ)抽出物、ワレモコウ(ジユ)抽出物が挙げられる。
【0025】
(細胞賦活剤)
細胞賦活剤としては、ビタミンA及びその誘導体(パルミチン酸レチノール、酢酸レチノール等のレチノール及びその誘導体、デヒドロレチナール等のレチナール及びその誘導体等)、カロチノイド(カロチン、リコピン、アスタキサンチン等)、ビタミンB及びその誘導体(チアミン塩酸塩、チアミン硫酸塩、リボフラビン、酢酸リボフラビン、塩酸ピリドキシン、ピリドキシンジオクタノエート、フラビンアデニンジヌクレオチド、シアノコバラミン、葉酸類、ニコチン酸アミド、ニコチン酸ベンジル等のニコチン酸類、コリン類等)、ビタミンC及びその誘導体(ジパルミチン酸−L−アスコルビルやテトライソパルミチン酸−L−アスコルビル等のL−アスコルビン酸アルキルエステル、L−アスコルビン酸リン酸エステル、L−アスコルビン酸硫酸エステル等)、リボ核酸及びその塩、デオキシリボ核酸及びその塩、α−及びγ−リノレン酸、キサンチン及びその誘導体(カフェイン等)、アーモンド抽出物、アスパラガス抽出物、アミノ酸及びその誘導体(セリン、グルタミン酸、テアニン、ヒドロキシプロリン、ピロリドンカルボン酸等)、アンズ(キョウニン)抽出物、イチョウ抽出物、ドコサヘキサエン酸及びその誘導体、エイコサペンタエン酸及びその誘導体、キハダ(オウバク)抽出物、オオムギ(バクガ)抽出物、キウイ抽出物、キュウリ抽出物、クエン酸、乳酸、リンゴ酸、コハク酸、シイタケ抽出物、スギナ抽出物、センブリ抽出物、ダイズ抽出物、ナツメ(タイソウ)抽出物、ツボクサ抽出物、トウガラシ抽出物、トウキンセンカ抽出物、トマト抽出物、ニンニク抽出物、ニンジン抽出物、ヒノキチオール、ブクリョウ抽出物、ブドウ種子油、ブナノキ抽出物、ブナの芽抽出物、モモ抽出物、ユーカリ抽出物、ユリ抽出物、レタス抽出物、レモン抽出物、ローズマリー(マンネンロウ)抽出物、動物由来抽出物(イカスミ等軟体動物抽出物、貝殻抽出物、貝肉抽出物、魚肉抽出物、鶏冠抽出物、シルクプロテイン及びその分解物、胎盤抽出物、血清除蛋白抽出物、ローヤルゼリー、ラクトフェリン又はその分解物等)、酵母抽出物、微生物醗酵代謝産物(乳酸菌、ビフィズス菌等由来)、霊芝抽出物等が挙げられる。
【0026】
これらの細胞賦活剤のうち、特に好ましいものとしては、ビタミンA及びその誘導体、ビタミンC及びその誘導体、ピロリドンカルボン酸、酵母抽出物、霊芝抽出物、イチョウ抽出物、オオムギ(バクガ)抽出物、ニンジン抽出物が挙げられる。
【0027】
(紫外線防止剤)
紫外線防止剤としては、パラメトキシケイ皮酸−2−エチルヘキシル、4−tert−ブチル−4’−メトキシジベンゾイルメタン、オキシベンゾン及びその誘導体(2−ヒドロキシ−4−メトキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸ナトリウム等)、酸化チタン、微粒子酸化チタン、酸化亜鉛及び微粒子酸化亜鉛等が挙げられる。酸化チタン、酸化亜鉛等の無機粉体は、微粒子のものを用いるとより高い効果が発揮される。
【0028】
これらの紫外線防止剤のうち、特に好ましいものとしては、パラメトキシケイ皮酸−2−エチルヘキシル、4−tert−ブチル−4’−メトキシジベンゾイルメタン、酸化チタン、微粒子酸化チタン、酸化亜鉛及び微粒子酸化亜鉛が挙げられる。
【0029】
本発明の皮膚外用剤における上記成分(B)の薬効剤の配合量は、薬効剤の種類により相違するが、以下に示す範囲とすることが好ましい。この範囲であれば、成分(A)のカトレア類の植物抽出物と組み合わせた場合、製剤及び製剤中の成分(A)のカトレア類の植物抽出物の経時安定性に影響を及ぼすことがなく、より高い美白効果、皮膚老化防止及び肌あれ改善効果を相乗的に発揮させることができる。
【0030】
すなわち、本発明の皮膚外用剤における成分(B)の美白剤の配合量は、好ましくは0.00001〜10%であり、より好ましくは0.0001〜5%の範囲である。抽出物を抽出液のまま用いる場合は乾燥固形分としてこの範囲であれば良い。この範囲であればより優れた美白効果、皮膚老化防止及び肌あれ改善効果を相乗的に示し、かつ、使用感の非常に良好な皮膚外用剤が得られる。
【0031】
本発明の皮膚外用剤における成分(B)の抗酸化剤の配合量は、好ましくは0.00001〜5%、より好ましくは0.0001〜3%の範囲である。抽出物を抽出液のまま用いる場合は乾燥固形分としてこの範囲であれば良い。この範囲であればより優れた抗酸化効果の発現がみられ、かつ、極めて優れた美白効果、皮膚老化防止及び肌あれ改善効果を示す皮膚外用剤が得られる。
【0032】
本発明の皮膚外用剤における成分(B)の抗炎症剤の配合量としては、0.00001〜5%の範囲が好ましく、より好ましくは0.0001〜3%の範囲である。植物抽出物を抽出液のまま用いる場合は乾燥固形分としてこの範囲であれば良い。この範囲であればより優れた抗炎症効果がみられ、かつ、優れた美白効果、皮膚老化防止及び肌あれ改善効果を相乗的に示す皮膚外用剤が得られる。
【0033】
本発明の皮膚外用剤における成分(B)の細胞賦活剤の配合量としては、好ましくは0.00001〜5%、より好ましくは0.0001〜3%の範囲である。抽出物を抽出液のまま用いる場合は、乾燥固形分としてこの範囲であれば良い。この範囲であればより極めて優れた肌荒れ改善効果が発現し、かつ、優れた高い美白効果、皮膚老化防止及び肌あれ改善効果を相乗的に示す皮膚外用剤が得られる。
【0034】
本発明の皮膚外用剤における成分(B)の紫外線防止剤の配合量としては、好ましくは0.001〜30%、より好ましくは0.01〜25%の範囲である。この範囲であればより優れた紫外線防止効果が発現し、かつ、優れた美白効果、皮膚老化防止及び肌あれ改善効果を相乗的に示す皮膚外用剤が得られる。
【0035】
これらの美白剤、抗酸化剤、抗炎症剤、細胞賦活剤及び紫外線防止剤は、一種又は二種以上を組み合わせて用いることができる。
【0036】
上記の成分(A)と成分(B)を組み合せた皮膚外用剤も、常法に従い、必須成分である成分(A)と成分(B)とを通常の皮膚外用剤として知られる種々の形態の基剤に配合して調製することができる。
【0037】
皮膚外用剤の配合形態の例としては、特に限定されず、例えば、乳液、クリーム、化粧水、パック、洗浄料、メーキャップ化粧料、分散液、軟膏、液剤、エアゾール、貼付剤、パップ剤、リニメント剤等の、いずれの形態の化粧料であっても、外用医薬品等であっても良い。
【0038】
又、本発明の皮膚外用剤には、前記必須成分以外のもので、化粧料や医薬部外品、外用医薬品等に通常使用される各種の成分、即ち、水、アルコール、油剤、界面活性剤、増粘剤、粉体、キレート剤、pH調整剤、各種薬効剤、動植物・微生物由来の抽出物、香料等を、本発明の効果を損なわない範囲で適宜加えることができる。これらの中から、具体的なものを以下に例示する。
【0039】
アルコールとしては、エチルアルコール等の一価アルコールや、グリセリン、1,3−ブチレングリコール等の多価アルコールを溶解、清涼感、防腐、保湿等の目的で用いることができる。
【0040】
油剤は、使用性、使用感を良くするものとして、その由来、性状は問わず使用することができる。例えば、流動パラフィン、スクワラン、トリグリセライド油、エステル油、ロウ類、脂肪酸類、高級アルコール、シリコン油、フッ素系油、各種ワックス等である。
【0041】
界面活性剤は、油剤等の乳化や可溶化等のために用いられ、陰イオン性、陽イオン性、非イオン性及び両性の活性剤を用いることができる。
【0042】
増粘剤としては、カルボキシビニルポリマー、カラギーナン、寒天、キサンタンガム、デキストリン脂肪酸エステル、有機変性粘土鉱物等、化学合成品又は天然物由来に関わらず用いることが可能である。又、これらの成分を系の粘度調整だけでなく、ゲル化、保湿、皮膜形成等の為に用いることもできる。
【0043】
粉体としては、形状や粒子の大きさ、多孔性の有無、結晶構造等を問わず、タルク、マイカ、セリサイト、無水ケイ酸等の無機粉体、ナイロンパウダー等の有機粉体、魚鱗箔、オキシ塩化ビスマス等のパール顔料、酸化鉄、カーボンブラック、群青等の無機顔料、タール色素及びそのレーキ、天然色素等が挙げられる。使用性や使用感を良くする為に、これらを複合化や表面処理を行なったものでも良く、用途に応じて用いられる。
【0044】
系中の成分の品質劣化を防ぐ為に、EDTA等のキレート剤、乳酸−乳酸ナトリウム等のバッファーによるpH調整剤、パラオキシ安息香酸エステル、安息香酸、安息香酸ナトリウム、フェノキシエタノール等の防腐剤を用いることもできる。
【0045】
(B)成分以外の薬効剤としては、合成品や、動植物・微生物由来のもの等が挙げられる。その起源や由来等に限定はなく、例えば、抗菌剤、殺菌剤、保湿剤、血行促進剤、酵素等が挙げられる。
抗菌剤及び殺菌剤としては、ニキビ等を予防、改善する目的で、パラクロルメタクレゾール、塩化ベンザルコニウム、イソプロピルメチルフェノール等が用いられる。これらを配合することにより、ニキビ等、細菌性の皮膚の炎症を抑制し、更に高い美白効果、皮膚老化防止及び肌あれ改善効果を発揮することができる。
【0046】
保湿剤としては、グリセリン、1,3−ブチレングリコール、タンパク質またはそれらの誘導体もしくは加水分解物並びにそれらの塩(コラーゲン、エラスチン、ケラチン等)、ムコ多糖及びその誘導体(ヒアルロン酸等)、糖類(ソルビトール、エリスリトール、トレハロース、イノシトール、グルコース、キシリトール、蔗糖及びその誘導体、デキストリン及びその誘導体、ハチミツ等)、D−パンテノール及びその誘導体、糖脂質、セラミド、アマチャ抽出物、アボカド抽出物、温泉水、ウスベニアオイ抽出物、オウレン抽出物、オドリコソウ抽出物、オノニス抽出物、カラスムギ抽出物、クインスシード抽出物、クチナシ抽出物、クマザサ抽出物、グレープフルーツ抽出物、ゴボウ抽出物、サボテン抽出物、サボンソウ抽出物、ジオウ抽出物、シモツケ抽出物、ショウガ抽出物、ショウブ抽出物、セイヨウハッカ(ペパーミント)抽出物、ゼニアオイ(ウスベニタチアオイ)抽出物、センキュウ抽出物、タチジャコウソウ(タイム)抽出物、ツバキ抽出物、トウチュウカソウ抽出物、ドクダミ抽出物、ハッカ抽出物、ハマメリス抽出物、バラ抽出物、ヒノキ抽出物、ヒマワリ抽出物、フキタンポポ抽出物、ブッチャーズブルーム抽出物、プルーン抽出物、ヘチマ抽出物、ボダイジュ抽出物、マツ抽出物、マルメロ抽出物、マロニエ抽出物、ムチン、ヤグルマソウ抽出物、ライム抽出物、ラベンダー抽出物、リンゴ抽出物、大豆及び卵由来のリン脂質、尿素等が挙げられる。
更に、皮膚表面のシーリングによる保湿(エモリエント)剤として、ホホバ油、マカデミアナッツ油、オリーブ油、杏仁油、パーシック油、サフラワー油、ヒマワリ油、アボガド油、メドゥホーム油、ツバキ油、アーモンド油、エゴマ油、ゴマ油、ボラージ(ルリジサ)油、カカオ脂、シア脂等が挙げられる。
これらの保湿剤を配合することにより、より高い美白効果、皮膚老化防止及び肌あれ改善効果を実現することができる。
【0047】
血行促進剤としては、皮膚の血流を促すことによってメラニンの排出を促進する目的で、トウガラシチンキ、γ―オリザノール等が用いられ、酵素としてはリパーゼ、パパイン等が用いられる。
【0048】
【実施例】
次に参考例、試験例及び実施例を挙げて本発明を更に詳細に説明するが、本発明はこれらに何等制約されるものではない。
【0049】
参考例1 カトレア類の植物抽出物の製造
カトレア ビオラセア(C.violacea)、カトレア ラビアタ(C.labiata)、カトレア エロンガータ(C.elongata)、及びレリア プルプラタ(L.purpurata)の全草10gに、精製水、50vol%含水エチルアルコール溶液、エチルアルコールを各100mL加え、室温にて3日間抽出を行った後濾過して各抽出物を得た。これら抽出物の乾燥固形分は表1に記載した。
【0050】
【表1】
【0051】
参考例2 ヨクイニン抽出物の製造
ヨクイニン(日局)10gに、70vol%含水エチルアルコール100mLを加え、室温にて3日間抽出を行った後濾過してヨクイニン抽出物を得た。この時、ヨクイニン抽出物の乾燥固形分は0.8%であった。
【0052】
試験例1 細胞培養によるメラニン生成抑制及び細胞生存率試験
マウス由来のB16メラノーマ培養細胞を使用した。2枚の6穴プレートに10%FBS含有MEM培地を適量とり、B16メラノーマ細胞を播種し、37℃、二酸化炭素濃度5vol%中にて静置した。翌日、参考例1で得たカトレア ビオラセア(C.violacea)、カトレア ラビアタ(C.labiata)の50vol%含水エチルアルコール抽出物、カトレア エロンガータ(C.elongata)の50vol%含水エチルアルコール抽出物、レリア プルプラタ(L.purpurata)の50vol%含水エチルアルコール抽出物を、それぞれ最終濃度が0(対照)、300、500、1000μg/mLとなるように検体調製液を添加し混和した。培養5日目に培地を交換し、再度検体調製液を添加した。翌日、培地を除き、1枚のシャーレについて、細胞をリン酸緩衝液(pH7)にて洗浄した後回収し、B16メラノーマ培養細胞の白色化度を以下の判定基準にて評価した。
又、比較例として既にメラニン生成抑制作用のあることが知られている参考例2で得たヨクイニン抽出物についても同様の試験を行った。
【0053】
(判定基準)
++:対照に対してきわめて白色である。
+:対照に対してあきらかに白色である。
±:対照に対してやや白色である。
−:対照と同じ黒色である。
【0054】
残りの1枚のプレートについて、細胞をホルマリン固定後、1%クリスタルバイオレット溶液を添加し染色した。各検体濃度に対する細胞生存率をモノセレーター(オリンパス社製)で測定した。以上の結果を表2に示す。
【0055】
(結果)
【0056】
【表2】
【0057】
表2の結果から明らかな如く、カトレア ビオラセア(C.violacea)の50vol%含水エチルアルコール抽出物、カトレア ラビアタ(C.labiata)の50vol%含水エチルアルコール抽出物、カトレア エロンガータ(C.elongata)の50vol%含水エチルアルコール抽出物、レリア プルプラタ(L.purpurata)の50vol%含水エチルアルコール抽出物は、B16メラノーマ培養細胞に対する毒性が低いにもかかわらず高いメラニン生成抑制効果が認められた。従って、これらの抽出物は極めて優れたメラニン生成抑制作用を有することが明らかとなった。
【0058】
試験例2 脂質過酸化抑制効果試験
参考例1で製造したものを試料とし、下記測定方法にて脂質過酸化に対する抑制効果を調べた。
【0059】
(測定方法)
脂質過酸化抑制試験は、679型ランシマット装置(Metrohm社製)を用いて酸化誘導時間(脂質が酸化されはじめるまでの時間)の比較を行った。
すなわち、ヒマシ油3g中に参考例1で得たカトレア ビオラセア(C.violacea)のエチルアルコール抽出物、カトレア ラビアタ(C.labiata)のエチルアルコール抽出物、カトレア エロンガータ(C.elongata)のエチルアルコール抽出物、レリア プルプラタ(L.purpurata)のエチルアルコール抽出物をそれぞれ0.1%となるように混合した後、反応容器にセットし、120℃に加熱しながら、空気を送り込み試料を強制的に酸化させる。酸化により生成された分解生成物を水中に補足し、導電率の変化を電極によって測定した。対照として、同濃度のdl−α−トコフェロールを用いた。その結果を表3に示す。
【0060】
(結果)
【0061】
【表3】
【0062】
表3の結果から明らかな如く、カトレア ビオラセア(C.violacea)のエチルアルコール抽出物、カトレア ラビアタ(C.labiata)のエチルアルコール抽出物、カトレア エロンガータ(C.elongata)のエチルアルコール抽出物、レリアプルプラタ(L.purpurata)のエチルアルコール抽出物は、dl−α−トコフェロールと比較して酸化誘導時間が長いことから、高い脂質過酸化抑制効果を有することが明らかとなった。
【0063】
実施例1
クリーム:
表4に示す組成及び下記製法でクリームを調製し、カトレア ビオラセア(C.violacea)の精製水抽出物、カトレア ラビアタ(C.labiata)の精製水抽出物、カトレア エロンガータ(C.elongata)の精製水抽出物、レリア プルプラタ(L.purpurata)の精製水抽出物の美白効果及び皮膚老化防止効果を調べた。この結果を表4に示す。
【0064】
(組成及び結果)
【0065】
【表4】
【0066】
(製法)
A.成分(1)〜(6)、(11)を混合し、加熱して70℃に保つ。
B.成分(13)を加熱して70℃に保つ。
C.AにBを加え乳化する。
D.Cに成分(7)〜(10)及び(12)を混合した後、冷却してクリームを得た。
【0067】
(試験方法)
被験クリーム1品につき27〜54才の女性15名をパネルとし、毎日、朝と夜の2回、洗顔後に被験クリームの適量を顔面に塗布した。試験は12週間行った。塗布による美白効果及び皮膚老化防止を以下の基準によって評価した。
【0068】
(美白効果 評価基準)
<評価> <内 容>
有 効 肌のくすみが目立たなくなった。
やや有効 肌のくすみがあまり目立たなくなった。
無 効 使用前と変化なし。
(皮膚老化防止効果 評価基準)
<評価> <内 容>
有 効 肌のはり、つやが改善された。
やや有効 肌のはり、つやがやや改善された。
無 効 使用前と変化なし。
【0069】
表4の結果に示される如く、カトレア ビオラセア(C.violacea)の精製水抽出物を配合した本発明品1、カトレア エロンガータ(C.elongata)の精製水抽出物を配合した本発明品2」、レリア プルプラタ(L.purpurata)の精製水抽出物を配合した本発明品3のクリームは、これらを皮膚に適用することにより、肌の「くすみ」等の発生の防止、改善をすることができ、美しい肌とすることが明らかとなり、美白効果を有することが明らかとなった。また、肌のはり、つやが改善され、皮膚老化防止効果を有することが明らかとなった。
【0070】
実施例2
クリーム:
表5に示す組成及び下記製法でクリームを調製し、カトレア ビオラセア(C.violacea)の50vol%含水エチルアルコール抽出物と美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤を併用した場合の美白効果及び皮膚老化防止効果を調べた。この結果を表5に併せて示す。また、カトレア ラビアタ(C.labiata)の50vol%含水エチルアルコール抽出物についても同様に、表6に示す組成及び下記製法でクリームを調製し、美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤を併用した場合の美白効果及び皮膚老化防止効果を調べ、結果を表6に併せて示す。
【0071】
(組成及び結果)
【0072】
【表5】
【0073】
【表6】
【0074】
(製法)
A.成分(1)〜(6)、(10)、(13)及び(14)を混合し、加熱して70℃に保つ。
B.成分(16)の一部を加熱して70℃に保つ。
C.AにBを加え乳化する。
D.Cに成分(7)、(8)及び(15)と(16)の残部で溶解した(9)、(11)、(12)を混合した後、冷却してクリームを得た。
【0075】
(試験方法)及び(評価基準)
実施例1と同様に行った。
【0076】
表5及び6の結果に示される如く、カトレア ビオラセア(C.violacea)の50vol%含水エチルアルコール抽出物を配合した本発明品4のクリーム、カトレア ラビアタ(C.labiata)の50vol%含水エチルアルコール抽出物を配合した本発明品11のクリームは、これらを皮膚に適用することにより、肌の「くすみ」等の防止、改善し、美しい肌とすることができることが明らかであるが、更に、カトレア ビオラセア(C.violacea)の50vol%含水エチルアルコール抽出物と美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤を併用して配合した本発明品5〜10、カトレア ラビアタ(C.labiata)の50vol%含水エチルアルコール抽出物と美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤を併用して配合した本発明品12〜17を皮膚に適用することにより、カトレア ビオラセア(C.violacea)の50vol%含水エチルアルコール抽出物、カトレア ラビアタ(C.labiata)の50vol%含水エチルアルコール抽出物や美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤を単独で配合した外用剤を適用した場合に比べてより優れた肌の「くすみ」等の防止、改善効果や、肌のはり、つやの改善効果を相乗的に発揮し、美しい肌とすることが明らかとなった。
【0077】
実施例3. 化粧水
(成分) (%)
(1)グリセリン 10.0
(2)1,3−ブチレングリコール 6.0
(3)カトレア ビオラセア(C.violacea)の精製水抽出物*1 0.5
(4)クエン酸 0.1
(5)クエン酸ナトリウム 0.3
(6)精製水 残量
(7)ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.5
(8)エチルアルコール 8.0
(9)防腐剤 適量
(10)香料 適量
*1 参考例1で製造したもの
【0077】
(製法)
A.成分(1)〜(6)を混合溶解する。
B.成分(7)〜(10)を混合溶解する。
C.AとBを混合して均一にし、化粧水を得た。
【0078】
実施例4. 化粧水
(成分) (%)
(1)グリセリン 8.0
(2)1,3−ブチレングリコール 4.0
(3)ソルビトール(70%水溶液) 5.0
(4)カトレア エロンガータ(C.elongata)の精製水抽出物*1 0.5
(5)海藻抽出物*2 0.5
(6)センキュウ抽出物*3 0.5
(7)乳酸(50%水溶液) 0.1
(8)乳酸ナトリウム(50%水溶液) 0.3
(9)精製水 残量
(10)ポリオキシエチレン硬化ヒマシ油(60E.O.) 0.5
(11)エチルアルコール 10.0
(12)防腐剤 適量
(13)香料 適量
*1 参考例1で製造したもの
*2 一丸ファルコス社製
*3 丸善製薬社製
【0079】
(製法)
A.成分(1)〜(9)を混合溶解する。
B.成分(10)〜(13)を混合溶解する。
C.AとBを混合して均一にし、化粧水を得た。
【0080】
実施例5. 乳液
(成分) (%)
(1)モノステアリン酸ソルビタン 0.3
(2)モノオレイン酸ポリオキシエチレンソルビタン
(20E.O.) 0.1
(3)親油型モノステアリン酸グリセリル 0.2
(4)ステアリン酸 0.5
(5)セタノール 0.5
(6)オリーブスクワラン 3.0
(7)流動パラフィン 4.0
(8)トリ2−エチルヘキサン酸グリセリル 2.0
(9)ホホバ油 5.0
(10)ジメチルポリシロキサン 1.0
(11)水素添加大豆リン脂質 0.1
(12)酢酸dl−α−トコフェロール*1 0.05
(13)防腐剤 適量
(14)アルキル変性カルボキシビニルポリマー 0.1
(15)水酸化ナトリウム 0.05
(16)グリセリン 5.0
(17)1,3−ブチレングリコール 7.0
(18)精製水 残量
(19)エチルアルコール 5.0
(20)カトレア ラビアタ(C.labiata)の
50vol%含水エチルアルコール抽出物*2 0.1
(21)ヨクイニン抽出物*3 1.0
(22)ユキノシタ抽出物*4 1.0
(23)マルメロ抽出物*5 5.0
(23)ボダイジュ抽出物*6 1.0
(24)多孔質シリカ 3.0
(25)香料 適量
*1 エーザイ社製
*2 参考例1で製造したもの
*3 丸善製薬社製
*4 一丸ファルコス社製
*5 香栄興業社製
*6 A.M.I社製
【0081】
(製法)
A.成分(14)〜(18)を加熱混合し、70℃に保つ。
B.成分(1)〜(13)を加熱混合し、70℃に保つ。
C.AにBを加えて混合し、均一に乳化する。
D.Cを冷却後(19)〜(25)を加え、均一に混合して乳液を得た。
【0082】
実施例6. 乳液
(成分) (%)
(1)モノステアリン酸ソルビタン 0.3
(2)モノオレイン酸ポリオキシエチレンソルビタン
(20E.O.) 0.1
(3)親油型モノステアリン酸グリセリル 0.2
(4)ステアリン酸 0.5
(5)セタノール 0.5
(6)スクワラン 3.0
(7)流動パラフィン 4.0
(8)マカデミアナッツ油 2.0
(9)ブドウ種子油*1 0.5
(10)パーシック油*2 0.5
(11)トリ2−エチルヘキサン酸グリセリル 2.0
(12)ジメチルポリシロキサン 1.0
(13)水素添加大豆リン脂質 0.1
(14)セラミド*3 0.2
(15)ルチン*4 0.2
(16)防腐剤 適量
(17)カルボキシビニルポリマー 0.1
(18)水酸化ナトリウム 0.05
(19)グリセリン 5.0
(20)1,3−ブチレングリコール 7.0
(21)精製水 残量
(22)エチルアルコール 3.0
(23)カトレア エロンガータ(C.elongata)の
50vol%含水エチルアルコール抽出物*5 0.1
(24)酵母抽出物*6 3.0
(25)ワレモコウ抽出物*7 0.3
(26)マイカイカ抽出物*8 0.3
(27)プルーン抽出物*9 0.1
(28)多孔質シリカ 3.0
(29)香料 適量
*1 長岡香料社製
*2 日光ケミカルズ社製
*3 Cosmoferm社製
*4 シグマ社製
*5 参考例1で製造したもの
*6 丸善製薬社製
*7 丸善製薬社製
*8 丸善製薬社製
*9 丸善製薬社製
【0083】
(製法)
A.成分(17)〜(21)を加熱混合し、70℃に保つ。
B.成分(1)〜(16)を加熱混合し、70℃に保つ。
C.AにBを加えて混合し、均一に乳化する。
D.Cを冷却後(22)〜(29)を加え、均一に混合して乳液を得た。
【0084】
実施例3〜5及び実施例6はいずれも経時安定性に優れ、皮膚に適用することにより、日焼けによる肌の「くすみ」やシミやソバカスを防止し、透明感のある美しい肌にすることができ、肌のはり、つやの改善、肌のくすみや皮膚の老化を防止する効果に極めて優れた化粧水及び乳液であった。
【0085】
実施例7. 軟膏
(成分) (%)
(1)ステアリン酸 18.0
(2)セタノール 4.0
(3)dl−α−トコフェロール*1 0.2
(4)防腐剤 適量
(5)トリエタノールアミン 2.0
(6)グリセリン 5.0
(7)精製水 残量
(8)レリア プルプラタ(L.purpurata)の
50vol%含水エチルアルコール抽出物*2 1.0
(9)ヒスチジン*3 0.1
*1 エーザイ社製
*2 参考例1で製造したもの
*3 協和発酵社製
【0086】
(製法)
A.成分(5)、(6)及び(7)の一部を加熱混合し、75℃に保つ。
B.成分(1)〜(4)を加熱混合し、75℃に保つ。
C.AをBに徐々に加える。
D.Cを冷却しながら(7)の残部で溶解した(8)、(9)を加え、軟膏を得た。
【0087】
実施例8. 軟膏
(成分) (%)
(1)ステアリン酸 18.0
(2)セタノール 4.0
(3)防腐剤 適量
(4)トリエタノールアミン 2.0
(5)グリセリン 5.0
(6)精製水 残量
(7)カトレア ラビアタ(C.labiata)の
エチルアルコール抽出物*1 1.0
(8)オウゴン抽出物*2 0.3
(9)ピロリドンカルボン酸ナトリウム*3 0.3
*1 参考例1で製造したもの
*2 丸善製薬社製
*3 味の素社製
【0088】
(製法)
A.成分(4)、(5)及び(6)の一部を加熱混合し、75℃に保つ。
B.成分(1)〜(3)を加熱混合し、75℃に保つ。
C.AをBに徐々に加える。
D.Cを冷却しながら(6)の残部で溶解した(7)〜(9)を加え、軟膏を得た。
【0089】
実施例7、8は経時安定性に優れ、皮膚に適用することにより、肌の「くすみ」やシミやソバカスを防止し、透明感のある美しい肌にすることができ、肌のはり、つやの改善、皮膚の老化を防止することのできる軟膏であった。
【0090】
実施例9 美容液 (%)
(1)イソステアリン酸ポリオキシエチレン(50)硬化ヒマシ油 0.2
(2)水素添加大豆リン脂質 0.3
(3)グリセリン 7.0
(4)dl−α−トコフェロール*1 0.3
(5)カンゾウ抽出物*2 0.2
(6)コレステロール 0.1
(7)エチルアルコール 6.0
(8)ヒドロキシメトキシベンゾフェノンスルホン酸ナトリウム*3 0.2
(9)L−アスコルビン酸硫酸2ナトリウム 0.5
(10)クエン酸 0.01
(11)クエン酸ナトリウム 0.1
(12)キサンタンガム 0.1
(13)メチルセルロース 0.1
(14)紅茶抽出物*4 0.1
(15)ゴカヒ抽出物*5 0.1
(16)ブナの芽抽出物*6 0.1
(17)シャクヤク抽出物*7 0.1
(18)ニコチン酸アミド*8 0.05
(19)オウバク抽出物*9 0.1
(20)トマト抽出物*10 0.1
(21)オウバク抽出物*11 0.1
(22)防腐剤 適量
(23)香料 適量
(24)カトレア ビオラセア(C.violacea)の
エチルアルコール抽出物*12 1.0
(25)精製水 残量
*1 エーザイ社製
*2 丸善製薬社製
*3 湘南化学工業社製
*4 丸善製薬社製
*5 丸善製薬社製
*6 GATEFOSSE社製
*7 稲畑香料社製
*8 和光純薬社製
*9 丸善製薬社製
*10 エスペリス社製
*11 丸善製薬社製
*12 参考例1で製造したもの
【0091】
(製造方法)
A.成分(1)〜(7)を混合溶解する。
B.(8)〜(13)、(25)を加温混合し、室温まで冷却する。
C.BにAおよび(14)〜(24)を添加混合して、美容液を得た。
【0092】
実施例9は経時安定性に優れ、皮膚に適用することにより、肌の「くすみ」やシミやソバカスを防止し、透明感のある美しい肌にすることができ、肌のはり、つやの改善、皮膚の老化を防止する効果に極めて優れた美容液であった。
【0093】
実施例10. パック
(成分) (%)
(1)ポリビニルアルコール 15.0
(2)無水ケイ酸 0.5
(3)ポリエチレングリコール 0.5
(4)ポリオキシプロピレンメチルグルコシド 5.0
(5)グリセリン 5.0
(6)精製水 残量
(7)グリチルリチン酸ジカリウム*1 0.1
(8)エチルアルコール 10.0
(9)防腐剤 適量
(10)カトレア ビオラセア(C.violacea)の精製水抽出物*2 0.1
(11)カトレア エロンガータ(C.elongata)の
エチルアルコール抽出物*2 0.2
(12)イチョウ抽出物*3 0.2
(13)アルニカ抽出物*4 0.2
(14)緑茶抽出物*5 0.2
(15)香料 適量
*1 丸善製薬社製
*2 参考例1で製造したもの
*3 常磐植物化学研究所社製
*4 丸善製薬社製
*5 丸善製薬社製
【0094】
(製法)
A.成分(1)〜(7)を混合し、70℃に加熱して溶解する。
B.成分(8)及び(9)を混合し溶解する。
C.Bを先のAに加え、混合した後、冷却して成分(10)〜(15)を均一に分散してパックを得た。
【0095】
実施例11. パック
(成分) (%)
(1)ポリビニルアルコール 15.0
(2)カオリン 2.0
(3)酸化チタン 2.0
(4)ポリエチレングリコール 0.5
(5)ポリオキシプロピレンメチルグルコシド 3.0
(6)グリセリン 10.0
(7)精製水 残量
(8)エチルアルコール 20.0
(9)防腐剤 適量
(10)ローズマリー水*1 10.0
(11)レリア プルプラタ(L.purpurata)の
50vol%含水エチルアルコール抽出物*2 0.2
(12)ソウハクヒ抽出物*3 0.5
(13)コムギ抽出物*4 0.5
(14)ボタン抽出物*5 0.5
(15)ナツメ抽出物*6 0.5
(16)香料 適量
*1 丸善製薬社製
*2 参考例1で製造したもの
*3 丸善製薬社製
*4 成和化成社製
*5 一丸ファルコス社製
*6 丸善製薬社製
【0096】
(製法)
A.成分(1)〜(7)を混合し、70℃に加熱して溶解する。
B.成分(8)及び(9)を混合して溶解する。
C.Bを先のAに加え、混合した後、冷却して成分(10)〜(16)を均一に分散してパックを得た。
【0097】
実施例10及び11は経時安定性に優れ、皮膚に適用することにより、肌の「くすみ」やシミを防止し、透明感のある美しい肌にすることができ、肌のはり、つやの改善、皮膚の老化を防止するパックであった。
【0098】
実施例12. リキッドファンデーション:
(成分) (%)
(1)ジペンタエリトリット脂肪酸エステル 2.0
(2)流動パラフィン 5.0
(3)ステアリン酸 2.0
(4)セタノール 1.0
(5)自己乳化型モノステアリン酸グリセリル 1.0
(6)パラメトキシケイ皮酸−2−エチルヘキシル 8.0
(7)パルミチン酸レチノール*1 0.5
(8)酢酸−dl−α−トコフェロール*2 0.2
(9)防腐剤 適量
(10)グリセリン 5.0
(11)トリエタノールアミン 1.0
(12)カルボキシメチルセルロース 0.2
(13)ベントナイト 0.5
(14)精製水 残量
(15)酸化チタン 6.0
(16)微粒子酸化チタン 2.0
(17)微粒子酸化亜鉛 5.0
(18)マイカ 2.0
(19)タルク 4.0
(20)着色顔料 4.0
(21)カトレア ラビアタ(C.labiata)の
50vol%含水エチルアルコール抽出物*3 0.01
(22)マンニトール*4 0.1
(23)ニコチン酸アミド*5 0.5
(24)カンゾウ抽出物*6 0.1
(25)キウイ抽出物*7 0.1
(26)コーヒー抽出物*8 0.1
(27)香料 適量
*1 日本ロシュ社製
*2 エーザイ社製
*3 参考例1で製造したもの
*4 和光純薬社製
*5 シグマ社製
*6 丸善製薬社製
*7 一丸ファルコス社製
*8 一丸ファルコス社製
【0099】
(製法)
A.成分(1)〜(9)を加熱し混合溶解する。
B.Aに成分(15)〜(20)を加え、均一に混合し、70℃に保つ。
C.成分(10)〜(14)、(22)、(23)を均一に溶解し、70℃に保つ。
D.CにBを添加して、均一に乳化する。
E.Dを冷却後、成分(21)、(24)〜(27)を添加してリキッドファンデーションを得た。
【0100】
実施例13. リキッドファンデーション:
(成分) (%)
(1)ジペンタエリトリット脂肪酸エステル 2.0
(2)流動パラフィン 5.0
(3)ステアリン酸 2.0
(4)セタノール 1.0
(5)自己乳化型モノステアリン酸グリセリル 1.0
(6)パラメトキシケイ皮酸−2−エチルヘキシル 8.0
(7)4−tert−ブチル−4’
−メトキシジベンゾイルメタン 2.0
(8)グリチルレチン酸ステアリル*1 0.2
(9)防腐剤 適量
(10)グリセリン 5.0
(11)トリエタノールアミン 1.0
(12)カルボキシメチルセルロース 0.2
(13)ベントナイト 0.5
(14)精製水 残量
(15)酸化チタン 6.0
(16)微粒子酸化チタン 2.0
(17)微粒子酸化亜鉛 5.0
(18)マイカ 2.0
(19)タルク 4.0
(20)着色顔料 4.0
(21)カトレア エロンガータ(C.elongata)の
エチルアルコール抽出物*2 0.2
(22)シラユリ抽出物*3 0.1
(24)ホップ抽出物*4 0.1
(25)カミツレ抽出物*5 0.1
(26)アロエ抽出物*6 0.1
(27)香料 適量
*1 日本ロシュ社製
*2 参考例1で製造したもの
*3 日光ケミカルズ社製
*4 丸善製薬社製
*5 香栄興業社製
*6 丸善製薬社製
【0101】
(製法)
A.成分(1)〜(9)を混合溶解する。
B.Aに成分(15)〜(20)を加え、均一に混合し、70℃に保つ。
C.成分(10)〜(14)を均一に溶解し、70℃に保つ。
D.CにBを添加して、均一に乳化する。
E.Dを冷却後、成分(21)〜(27)を添加してリキッドファンデーションを得た。
【0102】
実施例14. 日焼け止め乳液
(成分) (%)
(1)ポリオキシアルキレン変性オルガノポリシロキサン 1.0
(2)ジメチルポリシロキサン 5.0
(3)オクタメチルシクロテトラシロキサン 20.0
(4)イソノナン酸イソトリデシル 5.0
(5)パラメトキシケイ皮酸−2−エチルヘキシル 5.0
(6)β−カロチン*1 0.001
(7)サフラワー油*2 0.5
(8)防腐剤 適量
(9)香料 適量
(10)微粒子酸化チタン 3.0
(11)微粒子酸化亜鉛 12.0
(12)ポリスチレン末 3.0
(13)トリメチルシロキシケイ酸 0.5
(14)ジプロピレングリコール 3.0
(15)エチルアルコール 10.0
(16)精製水 残量
(17)食塩 0.2
(18)マンニトール*3 0.05
(19)カトレア ビオラセア(C.violacea)の精製水抽出物*4 2.0
(20)ラベンダー水*5 5.0
(21)オレンジフラワー水*6 5.0
(22)キュウリ抽出物*7 0.5
(23)アルテア抽出物*8 0.5
(24)イラクサ抽出物*9 0.5
(25)ダイズ抽出物*10 0.5
*1 三共製薬社製
*2 日清製油社製
*3 和光純薬社製
*4 参考例1で製造したもの
*5 丸善製薬社製
*6 香栄興業社製
*7 一丸ファルコス社製
*8 香栄興業社製
*9 丸善製薬社製
*10 一丸ファルコス社製
【0103】
(製法)
A.成分(1)〜(13)を混合溶解する。
B.成分(14)〜(18)を混合溶解する。
C.AにBを添加して、均一に乳化する。
D.Cに成分(19)〜(25)を添加して日焼け止め乳液を得た。
【0104】
実施例15. 日焼け止め乳液
(成分) (%)
(1)ポリオキシアルキレン変性オルガノポリシロキサン 1.0
(2)ジメチルポリシロキサン 5.0
(3)オクタメチルシクロテトラシロキサン 20.0
(4)イソノナン酸イソトリデシル 5.0
(5)パラメトキシケイ皮酸−2−エチルヘキシル 8.0
(6)4−tert−ブチル−4’
−メトキシジベンゾイルメタン 2.0
(7)防腐剤 適量
(8)香料 適量
(9)シリコン処理微粒子酸化チタン 8.0
(10)シリコン処理微粒子酸化亜鉛 7.0
(11)ポリスチレン末 3.0
(12)トリメチルシロキシケイ酸 0.5
(13)ジプロピレングリコール 3.0
(14)エチルアルコール 10.0
(15)精製水 残量
(16)食塩 0.2
(17)レリア プルプラタ(L.purpurata)の
50vol%含水エチルアルコール抽出物*1 1.0
(18)リン酸−L−アスコルビルマグネシウム*2 3.0
(19)烏龍茶抽出物*3 0.1
(20)ゼニアオイ抽出物*4 1.0
(21)フキタンポポ抽出物*5 0.1
(22)サンザシ抽出物*6 0.1
(23)ローズマリー抽出物*7 0.1
*1 参考例1で製造したもの
*2 日光ケミカルズ社製
*3 一丸ファルコス社製
*4 A.M.I社製
*5 丸善製薬社製
*6 丸善製薬社製
*7 丸善製薬社製
【0105】
(製法)
A.成分(1)〜(12)を混合溶解する。
B.成分(13)〜(16)、(18)を混合溶解する。
C.AにBを添加して、均一に乳化する。
D.Cに成分(17)、(19)〜(23)を添加して日焼け止め乳液を得た。
【0106】
実施例12〜16は経時安定性に優れ、皮膚に適用することにより、日焼け等による肌の黒化やシミやソバカスを防止する効果に優れ、肌のくすみや荒れを抑え、皮膚の老化を防止する効果に優れるリキッドファンデーション及び日焼け止め乳液であった。
【0107】
【発明の効果】
以上の如く、本発明のカトレア類の植物抽出物を含有する皮膚外用剤は、優れたメラニン生成抑制作用を有しており、色素沈着に対し高い抑制効果を発揮し、肌のくすみ、日焼けなどによる皮膚の黒化、シミ、ソバカスの防止及び改善等に有効なものであり、また、皮膚中での活性酸素生成に起因する過酸化脂質の生成、炎症、黒化、老化等に対し極めて高い改善及び予防効果を有するものである。又、本発明のカトレア類の植物抽出物と、美白剤、抗酸化剤、抗炎症剤、細胞賦活剤、紫外線防止剤等の他の薬効剤を併用して配合した本発明の皮膚外用剤は、前記カトレア類の植物抽出物や他の薬効剤を単独で配合した場合に比べてより優れた美白及び/又は抗酸化効果を相乗的に示すものである。
従って、本発明の皮膚外用剤は、美白や老化を目的とする化粧品や医薬品等として有利に利用することができるものである。[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to orchids of the genus Cattleya (Cattleya), the genus Brassoccattleya, the genus Brassoleliocattleya, the genus Leliocattoleya, the genus Leliocatioa, and the genus Leliocatioa, Laelayatoniaia. , A skin external preparation containing a plant extract belonging to the genus Laelia, and more particularly to the orchids Cattleya, Brassocatrea, Brassoleliocatrea, Leriocatrea, Leriocatonia, Catreoptis, Catretonia, By containing a plant extract belonging to the genus Leria, dull skin, spots, freckles or aging Prevention of pigmentation, such as sexual pigmentation and chloasma and improvement as well as skin external agent having an excellent whitening effect of improving the clarity of the skin. The present invention also relates to an external preparation for skin having an effect of preventing skin aging and improving skin roughness by preventing the formation of lipid peroxide due to the generation of active oxygen in the skin, the inflammation, blackening, and aging of the skin. Further, the present invention relates to a skin external preparation in which the above-mentioned effects are further enhanced by combining these specific orchid plant extracts with other medicinal agents.
[0002]
[Prior art]
BACKGROUND ART Conventionally, skin external preparations such as emulsions, creams, lotions, packs, detergents, dispersions, ointments, solutions, aerosols, patches, cataplasms, and liniments are required to impart a predetermined medicinal effect to them. Various medicinal agents have been added for the purpose.
For example, whitening agents such as ascorbic acid, placental extract, glutathione, and hydroquinone have been added to prevent or ameliorate the darkening of the skin caused by sunburn and the like, and spots and freckles caused by pigmentation.
[0003]
Also, antioxidants such as vitamin E have been added for the purpose of preventing the formation of lipid peroxide and the inflammation, darkening and aging of the skin.
In recent years, as one of the causes of skin aging, the adverse effect of active oxygen on the living body has been cited. Active oxygen includes superoxide, singlet oxygen, hydroxyl radicals, hydrogen peroxide, etc., which are known to damage lipids, nuclei, proteins, and enzymes. If it occurs, it may lead to illness or death. In addition, at least in terms of quantity, accumulation of damage due to active oxygen lowers biological functions, which is a factor that causes a so-called aging phenomenon.
For this reason, various active oxygen removing agents have been developed.
[0004]
[Problems to be solved by the invention]
However, with the above-mentioned medicinal agents, the desired medicinal effect may not be obtained due to insufficient effect or deterioration in the preparation in some cases, and improvement thereof has been desired.
[0005]
[Means for Solving the Problems]
The present inventors have conducted intensive studies on components that can be used as medicinal components of an external preparation for skin, and as a result, have found that orchids of the genus Cattleya (Cattleya), genus Brassocacatleya, genus Brassoleliocattleya, and Leriocatreya. The genus (Laeiocattleya), the genus Leliocatonia (Laelicatonia), the genus Cattleyopsis (Catleyopsis), the genus Cattletonia (Catleytonia), the genus Lelia (Laelia) (hereinafter, the above genera may be collectively referred to as plants). It has been found that the extract has a high melanin production inhibitory action and an antioxidant action, and is excellent as a whitening and antioxidant component. The present inventors have found that this extract can be blended with a skin external preparation as a whitening component and / or an antioxidant component, and that a more excellent effect as a skin external preparation can be obtained by combining the extract with another medicinal agent. completed.
[0006]
That is, the present invention comprises a plant extract belonging to cattleyas as a whitening component and / or an antioxidant component, has an excellent whitening effect, and produces dullness, spots, freckles or senile pigment spots and liver It is intended to provide a skin external preparation for preventing and improving pigmentation such as spots and improving skin transparency. Further, a skin external preparation having an effect of preventing skin aging and improving skin roughness by preventing the generation of lipid peroxide due to the generation of active oxygen in the skin and preventing skin inflammation, blackening, and aging. It is.
[0007]
Further, the present invention comprises a plant extract of cattleyas, and one or more active agents selected from whitening agents, antioxidants, anti-inflammatory agents, cell activators and ultraviolet inhibitors. It is intended to provide a skin external preparation characterized by the following.
[0008]
BEST MODE FOR CARRYING OUT THE INVENTION
Cattleyas used in the present invention will be described. Plants belonging to the genus Cattleya of the family Orchidaceae are said to be the original species of Cattleya, and give flowers that are so beautiful that they are called queens of orchids. About 30 species of epiphytic orchids are distributed in the tropics of Central and South America. Many hybrids are produced by crossing with related genera, and are widely cultivated for cut flowers and potted flowers. Plants belonging to the genus Cattleya include Cattleya bicolor (C. bicolor), Cattleya aklandiae (C. alandiae), Cattleya aurantiaca (C. aurantiaca), Cattleya boulingia (C. bowlingiana), Cattleya leopoldi (C. C. leopoldii, Cattleya mendelii, C. porphyroglossa, C. skinneri, C. walkeriana, C. walkeriana f. C. rawrencana, Cattleya Intelmedia, Cattleya Bertina C. velutina, C. warneri, C. eldorado, C. mossiae, C. gaskeliana, C. perseviana, C. peraviariana C. ivaliana, C. lueddemanniana, C. jeanmani, C. eana, C. trianae, C. trianae, C. chocoensis, C. chocoensis Schroederae), Cattleya valsevichii, Cattle C. dowiana, C. rex, C. maxima, C. maxima, C. orole, C. luora, C. luteora, C. mooreana, C. mooreana, C. mooreana C. kerrii, Cattleya Araguaiensis, C. elongata, C. violacea, C. violacea, C. granulosa, C. granulosa, C. guatta, C. guatta. Iricolor), Cattleya rhodigesii, Cattleya sirriana (C. schirilliana), Cattleya labata (C. labiata) and the like.
[0009]
Leria is a closely related species of the genus Cattleya and is a orchid with approximately 50 species distributed in the tropics of Central and South America centering on Brazil, and Leria belonging to Leria albida and L. ancesps. , L. autumnaris, L. canariensis, L. cinnabarina, L. crispa, L. esalqueana, L. fulfuracea L. grandis, L. jongheana, L. lobata, L. longgipea, L. longphia Lundii), L. perrinii, L. pumila, L. purpurata, L. reginae, L. rubescens, L. sincorana or L. sincorana ), L. speciosa, L. tenebrosa, L. zip (L. zip) and the like.
[0010]
Cattleyopsis is a closely related species of the genus Cattleya, and is a beautiful epiphytic or rocky orchid with three species distributed in the West Indies. Cattleopsis spp. lindenii (Catalyopsis Lindenii) and the like.
[0011]
The genus Brassocattleya, the genus Brassoleliocattleya, the genus Laeriocattleya, the genus Laliocatonia and the genus Catalonia, and the genus Cattlenia, to the genus Laetioatonia and Laetiatonia, including the genus Cattlenia and Cattlenia. It is an artificial species that has been made. There are a great many types of these orchids, and they are beautiful orchids that follow the characteristics of Cattleya and its closely related species.
[0012]
The above cattleya plants are rich in phenolic compounds, carotenoids, SOD, catalase, vitamins, and the like, and it is considered that these components exert a complexing effect of whitening and antioxidation.
[0013]
In producing the extract used in the present invention, the type and place of production of cattleya are not particularly limited. The method for preparing the extract is not particularly limited, and examples thereof include extracting from the whole plant or at least one of roots, stems, sprouts, leaves, flowers, seeds, etc. After subjecting them to appropriate treatment such as drying, shredding, squeezing, or fermentation, extraction with a solvent at a low temperature or at a temperature from room temperature to a heating temperature can be mentioned. The obtained extract can be used as a solution, a paste, a gel, or a powder by subjecting it to filtration or purification using an ion exchange resin or the like and performing purification such as adsorption and decolorization. If necessary, purification treatment such as deodorization and decolorization may be performed within a range that does not affect the effect. Also, supercritical extraction and extraction by steam distillation are suitably used.
[0014]
As the extraction solvent, for example, water, lower monohydric alcohol (methyl alcohol, ethyl alcohol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohol (glycerin, propylene glycol, 1,3 -Butylene glycol, etc.), lower alkyl esters (ethyl acetate, etc.), hydrocarbons (benzene, hexane, pentane, etc.), ketones (acetone, methyl ethyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, dipropyl ether, etc.), acetonitrile And the like, and one kind or two or more kinds can be used.
[0015]
Further, as an example of a preferable extraction method, extraction is carried out at room temperature or by heating for 1 to 5 days using aqueous ethyl alcohol or 1,3-butylene glycol having a concentration of 0 to 100 vol%, followed by filtration. The obtained filtrate is allowed to stand for about one week, aged, and then filtered again.
[0016]
The content of the plant extract of cattleya in the external preparation for skin of the present invention is preferably 0.00001 to 5% by mass (hereinafter simply referred to as “%”) as a dry solid content, and more preferably 0.0001 to 5%. 2%. When the content is within this range, the plant extract can be stably compounded, and high whitening and antioxidant effects can be exhibited. When an extract is used, the concentration of the extract is not limited at all if the content of the dry solid content as a solute is within the above range.
[0017]
The plant extract of cattleyas of the present invention is used as a skin whitening and antioxidant component in accordance with a conventional method, mixed with various forms of bases used for normal skin external preparations, and formulated into a skin external preparation. Can be obtained, but by further combining with other medicinal agents, a skin external preparation having more excellent whitening and antioxidant effects can be obtained.
[0018]
In the present invention, other medicinal agents (component (B)) used in combination with the plant extract of cattleya (component (A)) are a whitening agent, an antioxidant, an anti-inflammatory agent, a cell activator, and a UV ray preventive agent. Although it is selected from agents, specific pharmaceutical agents include, for example, those shown below. However, those having a plurality of medicinal effects are redundantly listed as the corresponding medicinal agents. Here, the “derivative” includes esters and salts that can be formed. Furthermore, in parentheses, other names of plants, names of crude drugs and the like are described.
[0019]
(Whitening agent)
As whitening agents, vitamin C and its derivatives (alkyl L-ascorbic acid such as di-palmitic acid-L-ascorbyl, tetraisopalmitic acid-L-ascorbyl), L-ascorbic acid phosphate, L-ascorbic acid sulfate Etc.), placenta extract, glabridine, glabrene, liquiritin, isoliquiritin and a liquorice extract containing them, yoquinin (barley) extract, koganebana (ogon) extract, seaweed extract (kelp, makombu, wakame, hijiki, hibamata) Brown algae such as seaweed, squirrel, trollocum, swordfish, swordfish, tycaiso, hondawara, and giant kelp; Red algae; green algae such as Chlorella, Aonori, Donariella, Chlorococcus, Anaoasa, Kawanori, marimo, shiogusa, casa nori, phtojuzmo, Tamajuzumo, human exa, amidro, etc .; Cyanobacteria such as Spirulina); Wheat extract, tomato extract, carotenoids (carotene, lycopene, astaxanthin, etc.), agarose, oligosaccharides, hydroquinone and its derivatives, cysteine and its derivatives, asparagus extract, ibukitorano extract, Neubara (Eijitsu) extract, Eleuthero extract, pea extract, chamomile extract, cayenne extract, orange extract, raspberry extract, kiwi extract, Clara (Kudin) extract, coffee extract, sesame oil, perilla oil, kokahi extract, rice Exudates, rice bran extract, saishin extract, hawthorn extract, sampens (Karaoketsumei) extract, peonies extract, shirayuri extract, mulberry (sohakuhiku) extract, oyster extract, beech extract, beech bud extract , Blackcurrant extract, hop extract, Maikaika (Maikai, Hamanas) extract, Mokka (bokeh) extract, Saxifraga extract, tea extract (such as oolong tea, black tea, green tea), Reishi extract, microbial fermentation metabolism Products, soybean extract, molasses extract, Arhat extract and the like.
[0020]
Among these whitening agents, particularly preferred are vitamin C and its derivatives, licorice extract, barley (Yokuinin) extract, wheat extract, mulberry (sour birch) extract, seaweed extract and tea extract. Can be
[0021]
(Antioxidant)
Examples of antioxidants include vitamin E and its derivatives (dl-α (β, γ) -tocopherol, dl-α-tocopherol acetate, dl-α-tocopherol nicotinate, dl-α-tocopherol linoleate, succinic acid) tocopherols and derivatives thereof such as dl-α-tocopherol, ubiquinones and the like; vitamin A and derivatives thereof (retinol and derivatives thereof such as retinol palmitate and retinol acetate; retinal and derivatives thereof such as dehydroretinal and the like); carotenoids (carotene , Lycopene, astaxanthin, etc.), quercetin, dibutylhydroxytoluene, butylhydroxyanisole, vitamin B and its derivatives (thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine diocta) Benzoate, flavin adenine dinucleotide, cyanocobalamin, folic acids, nicotinic acid amide, nicotinic acid benzyl nicotinate and the like, choline, etc.), vitamin C. And derivatives thereof (e.g., L-ascorbic acid alkyl esters such as dipalmitic acid-L-ascorbyl and tetraisopalmitic acid-L-ascorbyl, L-ascorbic acid phosphate, L-ascorbic acid sulfate, etc.), vitamin D and the like. Derivatives (ergocalciferol, cholecalciferol, dihydroxystannal, etc.), rutin and its derivatives, thiotaurine, taurine, hydroquinone and its derivatives, histidine, catechin and its derivatives, glabridine, glabrene, liquiritin, isoliquiritin and liquorice containing these Extract, glutathione and its derivatives, gallic acid and its derivatives, cucumber extract, calyx extract, gentian (gentian) extract, gennoshoko extract, cholesterol and its Conductor, hawthorn extract, peonies extract, superoxide dismutase, ginkgo extract, Scutellaria extract (carrot), carrot extract, maikaika (maikai, hamanas) extract, sampens (kawaragetsumei) extract, tormentilla extract, parsley Extract, grape extract, button (Pepper) extract, mannitol, mocca (bokeh) extract, melissa extract, yasajitsu (yashi) extract, snowy oak extract, rosemary (mannen wax) extract, lettuce extract, Tea extracts (such as oolong tea, black tea, and green tea), microbial fermentation metabolites, seaweed extracts, Ganoderma extracts, eggshell membrane extracts, placenta extracts, and Lohan fruit extracts.
[0022]
Among these antioxidants, particularly preferred are vitamin E and its derivatives, vitamin C. And its derivatives, rutin and its derivatives, yasujitsu extract, saxifrage extract, silkworm extract, superoxide dismutase, ginkgo extract, glutathione and its derivatives, histidine, mannitol, and carotenoid.
[0023]
(Anti-inflammatory)
Examples of anti-inflammatory agents include glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, vitamin B and its derivatives (thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, flavin adenine dinucleotide) , Nicotinic acid such as cyanocobalamin, folate, nicotinamide, benzyl nicotinate, choline, etc.), aloe extract, ashitaba extract, altea extract, arnica extract, sulfur and its derivatives, nettle extract, intinko ( Artemisia extract, turmeric extract, yellowfin (Otaku) extract, Hypericum extract, chamomile extract, Comfrey (Hypericum perforatum) extract, honeysuckle (Kinginka) extract, watercress extract, salvia (sage) extract, Remoko (Jiyu) extract, Perilla extract, Birch extract, Elderberry extract, Sesame extract (Elephant), Mukuroji extract, Eucalyptus extract, Artemisia extract, Astragalus extract, Chondroitin sulfate and its derivatives, Zinc oxide And the like.
[0024]
Among these anti-inflammatory agents, particularly preferred are glycyrrhizic acid and its derivatives, glycyrrhetinic acid and its derivatives, comfrey (Hypericum perforatum) extract, and Warmoko (Jiyu) extract.
[0025]
(Cell activator)
Examples of the cell activator include vitamin A and its derivatives (retinol and derivatives thereof such as retinol palmitate and retinol acetate, retinal and derivatives thereof such as dehydroretinal), carotenoids (carotene, lycopene, astaxanthin, and the like), vitamin B and its derivatives. Derivatives (thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, flavin adenine dinucleotide, cyanocobalamin, folic acids, nicotinic acid such as nicotinamide, benzyl nicotinate, choline, etc.) , Vitamin C and its derivatives (alkyl L-ascorbic acid such as di-palmitic acid-L-ascorbyl and tetraisopalmitic acid-L-ascorbyl), L-ascorbic acid phosphate, L-A Ribonucleic acid and its salts, deoxyribonucleic acid and its salts, α- and γ-linolenic acid, xanthine and its derivatives (such as caffeine), almond extract, asparagus extract, amino acid and its derivatives (Serine, glutamic acid, theanine, hydroxyproline, pyrrolidone carboxylic acid, etc.), apricot (kyonin) extract, ginkgo extract, docosahexaenoic acid and its derivatives, eicosapentaenoic acid and its derivatives, yellowfin (Obak) extract, barley (Bakuga) ) Extracts, kiwi extracts, cucumber extracts, citric acid, lactic acid, malic acid, succinic acid, shiitake extract, horsetail extract, assembly extract, soybean extract, jujube (traditional) extract, syllium extract, Capsicum extract, Calendula extract, Tomato extract , Garlic extract, carrot extract, hinokitiol, bougainvillea extract, grape seed oil, beech extract, beech bud extract, peach extract, eucalyptus extract, lily extract, lettuce extract, lemon extract, rose Marie (mannan wax) extract, animal-derived extract (mollusc extract such as cuttlefish, shell extract, shell meat extract, fish meat extract, cockscomb extract, silk protein and its degradation product, placenta extract, serum deproteinized Extract, royal jelly, lactoferrin or a degradation product thereof), yeast extract, metabolite of fermentation of microorganisms (derived from lactic acid bacteria, bifidobacteria, etc.), reishi extract and the like.
[0026]
Among these cell activators, particularly preferred are vitamin A and its derivatives, vitamin C and its derivatives, pyrrolidonecarboxylic acid, yeast extract, ganoderma extract, ginkgo extract, barley (Bakuga) extract, Carrot extract.
[0027]
(UV inhibitor)
Examples of UV inhibitors include 2-ethylhexyl paramethoxycinnamate, 4-tert-butyl-4'-methoxydibenzoylmethane, oxybenzone and derivatives thereof (2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4- Methoxybenzophenone-5-sulfonic acid, sodium 2-hydroxy-4-methoxybenzophenone-5-sulfonate), titanium oxide, fine titanium oxide, zinc oxide, fine zinc oxide and the like. The use of fine particles of inorganic powder such as titanium oxide and zinc oxide provides a higher effect.
[0028]
Among these UV inhibitors, particularly preferred are 2-ethylhexyl paramethoxycinnamate, 4-tert-butyl-4'-methoxydibenzoylmethane, titanium oxide, fine titanium oxide, zinc oxide and fine oxide. Zinc.
[0029]
Although the compounding amount of the above-mentioned component (B) in the external preparation for skin of the present invention varies depending on the kind of the above-mentioned drug, it is preferably within the following range. Within this range, when combined with the plant extract of Cattleya as the component (A), it does not affect the stability over time of the preparation and the plant extract of Cattleya as the component (A) in the formulation. A higher whitening effect, a skin aging prevention effect, and a skin roughness improvement effect can be synergistically exhibited.
[0030]
That is, the compounding amount of the whitening agent of the component (B) in the external preparation for skin of the present invention is preferably 0.00001 to 10%, more preferably 0.0001 to 5%. When the extract is used as it is as the extract, the dry solid content may be within this range. Within this range, a skin external preparation having a more excellent skin-whitening effect, a skin aging prevention effect and a skin roughness improvement effect, and having a very good feeling in use can be obtained.
[0031]
The compounding amount of the antioxidant of the component (B) in the external preparation for skin of the present invention is preferably in the range of 0.00001 to 5%, more preferably 0.0001 to 3%. When the extract is used as it is as the extract, the dry solid content may be within this range. Within this range, a more excellent antioxidant effect can be obtained, and an external preparation for the skin showing an extremely excellent whitening effect, prevention of skin aging and improvement of skin roughness can be obtained.
[0032]
The compounding amount of the anti-inflammatory agent of the component (B) in the external preparation for skin of the present invention is preferably in the range of 0.00001 to 5%, more preferably in the range of 0.0001 to 3%. When the plant extract is used as it is, the extract may be in this range as a dry solid content. Within this range, a skin external preparation that exhibits a more excellent anti-inflammatory effect and a synergistic effect of an excellent whitening effect, a prevention of skin aging and an improvement in skin roughness can be obtained.
[0033]
The compounding amount of the cell activator of the component (B) in the external preparation for skin of the present invention is preferably 0.00001 to 5%, more preferably 0.0001 to 3%. When the extract is used as it is as the extract, it may be in this range as a dry solid content. Within this range, a skin external preparation that exhibits an extremely excellent skin roughness improving effect and also has an excellent high whitening effect, skin aging prevention and skin roughness improvement effect synergistically can be obtained.
[0034]
The compounding amount of the ultraviolet ray inhibitor of the component (B) in the external preparation for skin of the present invention is preferably in the range of 0.001 to 30%, more preferably 0.01 to 25%. Within this range, a skin external preparation that exhibits a more excellent ultraviolet ray preventing effect and also has an excellent whitening effect, a skin aging prevention effect and a skin roughness improvement effect synergistically can be obtained.
[0035]
These whitening agents, antioxidants, anti-inflammatory agents, cell activators and UV inhibitors can be used alone or in combination of two or more.
[0036]
Skin external preparations obtained by combining the above-mentioned components (A) and (B) are also prepared according to a conventional method, using the essential components (A) and (B) in various forms known as ordinary skin external preparations. It can be prepared by mixing with a base.
[0037]
Examples of the formulation of the external preparation for skin are not particularly limited, and include, for example, emulsions, creams, lotions, packs, detergents, makeup cosmetics, dispersions, ointments, solutions, aerosols, patches, cataplasms, and liniments. It may be any form of cosmetics such as preparations or external medicines.
[0038]
In addition, the external preparation for skin of the present invention includes various components other than the above-mentioned essential components, which are usually used in cosmetics, quasi-drugs, external medicines, and the like, that is, water, alcohols, oils, and surfactants. , A thickener, a powder, a chelating agent, a pH adjuster, various medicinal agents, an extract derived from animals and plants / microorganisms, a fragrance, and the like can be appropriately added as long as the effects of the present invention are not impaired. Specific examples are shown below.
[0039]
As the alcohol, a monohydric alcohol such as ethyl alcohol or a polyhydric alcohol such as glycerin or 1,3-butylene glycol can be used for the purpose of dissolving, refreshing, preserving, moisturizing and the like.
[0040]
The oil agent can be used irrespective of its origin and properties so as to improve usability and usability. For example, liquid paraffin, squalane, triglyceride oil, ester oil, waxes, fatty acids, higher alcohols, silicone oil, fluorine-based oil, various waxes and the like.
[0041]
Surfactants are used for emulsification and solubilization of oils and the like, and anionic, cationic, nonionic and amphoteric surfactants can be used.
[0042]
As the thickener, it is possible to use a carboxyvinyl polymer, carrageenan, agar, xanthan gum, dextrin fatty acid ester, organically modified clay mineral, etc., regardless of the origin of a chemically synthesized product or a natural product. In addition, these components can be used not only for adjusting the viscosity of the system but also for gelling, moisturizing, forming a film, and the like.
[0043]
Regarding the powder, inorganic powder such as talc, mica, sericite, silicic acid, etc., organic powder such as nylon powder, fish scale foil, regardless of shape, particle size, porosity, crystal structure, etc. And inorganic pigments such as iron oxide, carbon black and ultramarine blue, tar pigments and lakes thereof, and natural pigments. In order to improve usability and usability, these may be subjected to compounding or surface treatment, and used depending on the application.
[0044]
Use chelating agents such as EDTA, pH adjusters with buffers such as lactic acid-sodium lactate, and preservatives such as paraoxybenzoate, benzoic acid, sodium benzoate, and phenoxyethanol to prevent quality deterioration of components in the system. Can also.
[0045]
Examples of the medicinal agent other than the component (B) include synthetic products and those derived from animals, plants and microorganisms. There is no limitation on the origin or origin, and examples thereof include antibacterial agents, bactericides, humectants, blood circulation promoters, enzymes and the like.
As an antibacterial agent and a bactericide, parachloromethcresol, benzalkonium chloride, isopropylmethylphenol and the like are used for the purpose of preventing and improving acne and the like. By blending them, bacterial skin inflammation such as acne can be suppressed, and a higher whitening effect, a prevention of skin aging and an effect of improving skin roughness can be exhibited.
[0046]
Examples of humectants include glycerin, 1,3-butylene glycol, proteins or their derivatives or hydrolysates, salts thereof (collagen, elastin, keratin, etc.), mucopolysaccharides and their derivatives (hyaluronic acid, etc.), sugars (sorbitol, etc.). Erythritol, trehalose, inositol, glucose, xylitol, sucrose and its derivatives, dextrin and its derivatives, honey, etc.), D-panthenol and its derivatives, glycolipids, ceramide, amacha extract, avocado extract, hot spring water, Usvenia oil Extracts, spinach extract, hydrangea extract, ononis extract, oats extract, quince seed extract, gardenia extract, kumazasa extract, grapefruit extract, burdock extract, cactus extract, sabonso extract, geo Extract, Spiraea extract, ginger extract, ginger extract, mint extract (peppermint) extract, mallow extract (Usubenitachiaoi) extract, senkyu extract, Tachikusou (thyme) extract, camellia extract, eucalypt extract Stuff, dokudami extract, peppermint extract, hamamelis extract, rose extract, hinoki extract, sunflower extract, coltsfoot extract, butchers bloom extract, prune extract, loofah extract, bodaiju extract, pine extract Quince extract, horse chestnut extract, mucin, cornflower extract, lime extract, lavender extract, apple extract, soybean and egg-derived phospholipids, urea and the like.
Further, moisturizing (emollient) agents by sealing the skin surface include jojoba oil, macadamia nut oil, olive oil, apricot oil, persic oil, safflower oil, sunflower oil, avocado oil, medouhome oil, camellia oil, almond oil, and sesame oil. Sesame oil, borage (borage) oil, cocoa butter, shea butter and the like.
By blending these humectants, higher whitening effect, prevention of skin aging and improvement effect of rough skin can be realized.
[0047]
As a blood circulation promoter, pepper tincture, γ-oryzanol, or the like is used for the purpose of promoting melanin excretion by promoting blood flow through the skin, and lipase, papain, or the like is used as an enzyme.
[0048]
【Example】
Next, the present invention will be described in more detail with reference to Reference Examples, Test Examples and Examples, but the present invention is not limited thereto.
[0049]
Reference Example 1 Production of plant extracts of cattleyas
Purified water, 50 vol% aqueous ethyl alcohol solution, ethyl alcohol in 10 g of whole plant of Cattleya violacea (C. violacea), Cattleya labita (C. labita), Cattleya elongata (C. elongata), and Lelia purpurata (L. purpurata) Was added at room temperature, and extracted at room temperature for 3 days, followed by filtration to obtain each extract. The dry solids of these extracts are listed in Table 1.
[0050]
[Table 1]
[0051]
Reference Example 2 Production of Yokuinin extract
To 10 g of Yokuinin (JP), 100 mL of 70 vol% aqueous ethyl alcohol was added, extracted at room temperature for 3 days, and filtered to obtain a Yokuinin extract. At this time, the dry solid content of the yokunin extract was 0.8%.
[0052]
Test Example 1 Melanin production suppression and cell viability test by cell culture
B16 melanoma cultured cells derived from mice were used. An appropriate amount of a MEM medium containing 10% FBS was taken in two 6-well plates, B16 melanoma cells were inoculated, and allowed to stand at 37 ° C. in a carbon dioxide concentration of 5 vol%. The next day, Cattleya violacea (C. violacea) obtained in Reference Example 1, 50 vol% aqueous ethyl alcohol extract of Cattleya labita (C. labita), 50 vol% aqueous ethyl alcohol extract of Cattleya elongata (C. elongata), Leria purpurata A sample preparation solution was added to and mixed with a 50 vol% aqueous ethyl alcohol extract of (L. purpurata) such that the final concentrations were 0 (control), 300, 500, and 1000 μg / mL, respectively. On the fifth day of the culture, the medium was changed, and the sample preparation solution was added again. On the next day, the medium was removed, and the cells were washed with a phosphate buffer (pH 7) and collected from one petri dish, and the whitening degree of the cultured B16 melanoma cells was evaluated according to the following criteria.
Further, as a comparative example, the same test was performed on the yoquinin extract obtained in Reference Example 2 which is already known to have a melanin production inhibitory action.
[0053]
(Judgment criteria)
++: extremely white with respect to the control.
+: Clearly white with respect to the control.
±: slightly white with respect to the control.
-: The same black color as the control.
[0054]
For the remaining one plate, the cells were fixed in formalin and stained with a 1% crystal violet solution. Cell viability for each sample concentration was measured with a monocerator (Olympus). Table 2 shows the above results.
[0055]
(result)
[0056]
[Table 2]
[0057]
As is clear from the results in Table 2, a 50 vol% aqueous ethyl alcohol extract of Cattleya violacea (C. violacea), a 50 vol% aqueous ethyl alcohol extract of Cattleya labita (C. labata), 50 vol% of cattleya elongata (C. elongata) % Hydrous ethyl alcohol extract and 50 vol% hydrous ethyl alcohol extract of L. purpurata (L. purpurata) showed a high melanin production inhibitory effect despite low toxicity to cultured B16 melanoma cells. Therefore, it became clear that these extracts have extremely excellent melanin production inhibitory action.
[0058]
Test Example 2 Lipid peroxidation inhibitory effect test
Using the sample produced in Reference Example 1 as a sample, the inhibitory effect on lipid peroxidation was examined by the following measurement method.
[0059]
(Measuring method)
In the lipid peroxidation inhibition test, the oxidation induction time (the time until lipid starts to be oxidized) was compared using a 679-type Rancimat apparatus (manufactured by Metrohm).
That is, in 3 g of castor oil, an ethyl alcohol extract of Cattleya violacea (C. violacea) obtained in Reference Example 1, an ethyl alcohol extract of Cattleya labita (C. labita), and an ethyl alcohol extract of Cattleya elongata (C. elongata). And the ethyl alcohol extract of L. purpurata were each mixed to a concentration of 0.1%, then set in a reaction vessel, and heated to 120 ° C. while sending air to forcibly oxidize the sample. Let it. Decomposition products generated by the oxidation were captured in water, and the change in conductivity was measured by electrodes. As a control, the same concentration of dl-α-tocopherol was used. Table 3 shows the results.
[0060]
(result)
[0061]
[Table 3]
[0062]
As is evident from the results in Table 3, an ethyl alcohol extract of Cattleya violacea (C. violacea), an ethyl alcohol extract of Cattleya labita (C. labita), an ethyl alcohol extract of Cattleya elongata (C. elongata), Leriapur The ethyl alcohol extract of plata (L. purpurata) was found to have a high lipid peroxidation inhibitory effect because the oxidation induction time was longer than that of dl-α-tocopherol.
[0063]
Example 1
cream:
A cream was prepared by the composition shown in Table 4 and the following method, and a purified water extract of Cattleya violacea (C. violacea), a purified water extract of Cattleya labita (C. labiata), and a purified water of Cattleya elongata (C. elongata) were prepared. The whitening effect and the skin aging prevention effect of the purified water extract of L. purpurata, an extract of L. purpurata, were examined. Table 4 shows the results.
[0064]
(Composition and results)
[0065]
[Table 4]
[0066]
(Production method)
A. Components (1) to (6) and (11) are mixed and heated to 70 ° C.
B. Heat component (13) to 70 ° C.
C. Add B to A and emulsify.
D. After mixing components (7) to (10) and (12) with C, the mixture was cooled to obtain a cream.
[0067]
(Test method)
For each test cream, 15 women aged 27 to 54 were used as a panel, and an appropriate amount of the test cream was applied to the face twice daily in the morning and evening after washing the face. The test was performed for 12 weeks. The whitening effect and the prevention of skin aging by application were evaluated according to the following criteria.
[0068]
(Whitening effect evaluation criteria)
<Evaluation><Contents>
Effective The dullness of skin became less noticeable.
Slightly effective The dullness of the skin became less noticeable.
Ineffective No change from before use.
(Skin aging prevention effect evaluation criteria)
<Evaluation><Contents>
Efficient Skin abrasion and gloss are improved.
Slightly effective Skin glue and luster slightly improved.
Ineffective No change from before use.
[0069]
As shown in the results in Table 4, the product of the present invention 1 containing a purified water extract of Cattleya violacea (C. violacea), the product of the present invention 2 containing a purified water extract of Cattleya elongata (C. elongata), The cream of the product 3 of the present invention containing a purified water extract of Leria purpurata (L. purpurata) can prevent and improve the occurrence of “dullness” on the skin by applying them to the skin, It became clear that the skin was beautiful, and that it had a whitening effect. In addition, it was revealed that skin abrasion and luster were improved and had an effect of preventing skin aging.
[0070]
Example 2
cream:
A cream was prepared according to the composition shown in Table 5 and the following method, and a 50 vol% aqueous ethyl alcohol extract of Cattleya violacea was used in combination with a whitening agent, an antioxidant, an anti-inflammatory agent, a cell activator, and a UV inhibitor. The whitening effect and the effect of preventing skin aging were examined. The results are shown in Table 5. Similarly, a cream containing 50 vol% of water-containing ethyl alcohol extract of Cattleya labita (C. labiata) was prepared according to the composition shown in Table 6 and the following method, and was used as a whitening agent, an antioxidant, an anti-inflammatory agent, and a cell activator. In addition, the whitening effect and the skin aging prevention effect when an ultraviolet inhibitor was used in combination were examined, and the results are shown in Table 6.
[0071]
(Composition and results)
[0072]
[Table 5]
[0073]
[Table 6]
[0074]
(Production method)
A. Components (1)-(6), (10), (13) and (14) are mixed and heated to 70 ° C.
B. Heat a portion of component (16) and maintain at 70 ° C.
C. Add B to A and emulsify.
D. After mixing components (7), (8) and (9), (11), and (12) dissolved in components (15) and the rest of (16) in C, the mixture was cooled to obtain a cream.
[0075]
(Test method) and (Evaluation criteria)
Performed in the same manner as in Example 1.
[0076]
As shown in the results of Tables 5 and 6, the cream of the product 4 of the present invention containing a 50 vol% aqueous ethyl alcohol extract of Cattleya violacea (C. violacea), and a 50 vol% aqueous ethyl alcohol extract of Cattleya labita (C. labiata) It is clear that the cream of the product 11 of the present invention containing such a substance can prevent and improve "dullness" of the skin and make the skin beautiful by applying these to the skin. (C. violacea) 50 to 50% aqueous ethyl alcohol extract and a whitening agent, an antioxidant, an anti-inflammatory agent, a cell activator, and an ultraviolet ray inhibitor in combination with the present invention products 5 to 10, Cattleya labata (C. violacea) Labiata) 50% by volume aqueous ethyl alcohol extract and whitening agent, antioxidant, anti-inflammatory agent, cell By applying the present invention products 12 to 17 combined with an activator and an ultraviolet ray inhibitor to the skin, a 50 vol% aqueous ethyl alcohol extract of cattleya violacea (C. violacea) and a cattleya labita (C. labiata) were obtained. 50% by volume of water-containing ethyl alcohol extract, skin lightening agent, anti-oxidant, anti-inflammatory agent, cell activator, ultraviolet light inhibitor It has been clarified that the effect of preventing and improving the skin and the effect of improving the skin shine and gloss are exhibited synergistically to make the skin beautiful.
[0077]
Embodiment 3 FIG. Lotion
(Ingredient) (%)
(1) Glycerin 10.0
(2) 1,3-butylene glycol 6.0
(3) Purified water extract of Cattleya violacea (C. violacea) * 1 0.5
(4) Citric acid 0.1
(5) Sodium citrate 0.3
(6) Remaining amount of purified water
(7) Polyoxyethylene hydrogenated castor oil (60EO) 0.5
(8) Ethyl alcohol 8.0
(9) Preservative appropriate amount
(10) Suitable amount of fragrance
* 1 Manufactured in Reference Example 1
[0077]
(Production method)
A. Components (1) to (6) are mixed and dissolved.
B. Components (7) to (10) are mixed and dissolved.
C. A and B were mixed and made uniform to obtain a lotion.
[0078]
Embodiment 4. FIG. Lotion
(Ingredient) (%)
(1) Glycerin 8.0
(2) 1,3-butylene glycol 4.0
(3) Sorbitol (70% aqueous solution) 5.0
(4) Cattleya elongata (C. elongata) purified water extract * 1 0.5
(5) Seaweed extract * 2 0.5
(6) Rose extract * 3 0.5
(7) Lactic acid (50% aqueous solution) 0.1
(8) Sodium lactate (50% aqueous solution) 0.3
(9) Remaining amount of purified water
(10) Polyoxyethylene hydrogenated castor oil (60EO) 0.5
(11) Ethyl alcohol 10.0
(12) Preservative appropriate amount
(13) Appropriate amount of fragrance
* 1 Manufactured in Reference Example 1
* 2 manufactured by Ichimaru Falcos
* 3 Maruzen Pharmaceutical Co., Ltd.
[0079]
(Production method)
A. Components (1) to (9) are mixed and dissolved.
B. Components (10) to (13) are mixed and dissolved.
C. A and B were mixed and made uniform to obtain a lotion.
[0080]
Embodiment 5 FIG. Latex
(Ingredient) (%)
(1) Sorbitan monostearate 0.3
(2) Polyoxyethylene sorbitan monooleate
(20EO) 0.1
(3) Lipophilic glyceryl monostearate 0.2
(4) Stearic acid 0.5
(5) Cetanol 0.5
(6) Olive squalane 3.0
(7) Liquid paraffin 4.0
(8) Glyceryl tri-2-ethylhexanoate 2.0
(9) Jojoba oil 5.0
(10) Dimethyl polysiloxane 1.0
(11) Hydrogenated soybean phospholipid 0.1
(12) dl-α-tocopherol acetate * 1 0.05
(13) Preservative appropriate amount
(14) Alkyl-modified carboxyvinyl polymer 0.1
(15) Sodium hydroxide 0.05
(16) Glycerin 5.0
(17) 1,3-butylene glycol 7.0
(18) Remaining amount of purified water
(19) Ethyl alcohol 5.0
(20) Cattleya Labata (C. labiata)
50 vol% aqueous ethyl alcohol extract * 2 0.1
(21) Yokuinin extract * 3 1.0
(22) Saxifraga extract * 4 1.0
(23) Quince extract * 5 5.0
(23) Bodaiju extract * 6 1.0
(24) Porous silica 3.0
(25) Suitable amount of fragrance
* 1 Eisai products
* 2 Manufactured in Reference Example 1
* 3 Maruzen Pharmaceutical Co., Ltd.
* 4 Made by Ichimaru Falcos
* 5 Made by Koei Kogyo Co., Ltd.
* 6 A. M. I company
[0081]
(Production method)
A. The components (14) to (18) are mixed by heating and kept at 70 ° C.
B. Components (1) to (13) are mixed by heating and maintained at 70 ° C.
C. Add B to A, mix and emulsify uniformly.
D. After cooling C, (19) to (25) were added and mixed uniformly to obtain an emulsion.
[0082]
Embodiment 6 FIG. Latex
(Ingredient) (%)
(1) Sorbitan monostearate 0.3
(2) Polyoxyethylene sorbitan monooleate
(20EO) 0.1
(3) Lipophilic glyceryl monostearate 0.2
(4) Stearic acid 0.5
(5) Cetanol 0.5
(6) Squalane 3.0
(7) Liquid paraffin 4.0
(8) Macadamia nut oil 2.0
(9) Grape seed oil * 1 0.5
(10) Persic oil * 2 0.5
(11) Glyceryl tri-2-ethylhexanoate 2.0
(12) Dimethyl polysiloxane 1.0
(13) Hydrogenated soybean phospholipid 0.1
(14) Ceramide * 3 0.2
(15) Rutin * 4 0.2
(16) Preservative appropriate amount
(17) Carboxyvinyl polymer 0.1
(18) Sodium hydroxide 0.05
(19) Glycerin 5.0
(20) 1,3-butylene glycol 7.0
(21) Remaining amount of purified water
(22) Ethyl alcohol 3.0
(23) Cattleya elongata (C. elongata)
50 vol% aqueous ethyl alcohol extract * 5 0.1
(24) Yeast extract * 6 3.0
(25) Cracked beetle extract * 7 0.3
(26) Maikaika extract * 8 0.3
(27) Prune extract * 9 0.1
(28) Porous silica 3.0
(29) Suitable amount of fragrance
* 1 Nagaoka Inc.
* 2 Nikko Chemicals
* 3 Cosmoferm
* 4 Sigma
* 5 Manufactured in Reference Example 1
* 6 Maruzen Pharmaceutical Co., Ltd.
* 7 Maruzen Pharmaceutical Co., Ltd.
* 8 Maruzen Pharmaceutical Co., Ltd.
* 9 Maruzen Pharmaceutical Co., Ltd.
[0083]
(Production method)
A. The components (17) to (21) are mixed by heating and kept at 70 ° C.
B. The components (1) to (16) are mixed by heating and kept at 70 ° C.
C. Add B to A, mix and emulsify uniformly.
D. After cooling C, (22) to (29) were added and mixed uniformly to obtain an emulsion.
[0084]
Examples 3 to 5 and Example 6 are all excellent in stability over time, and can be applied to the skin to prevent "dullness" of the skin due to sunburn, spots and freckles, and to make the skin beautiful and transparent. It was a lotion and an emulsion which was extremely effective in improving skin abrasion and gloss, preventing dullness of the skin and preventing aging of the skin.
[0085]
Embodiment 7 FIG. ointment
(Ingredient) (%)
(1) Stearic acid 18.0
(2) Cetanol 4.0
(3) dl-α-tocopherol * 1 0.2
(4) Preservative appropriate amount
(5) Triethanolamine 2.0
(6) Glycerin 5.0
(7) Remaining amount of purified water
(8) Leria purpurata (L. purpurata)
50 vol% aqueous ethyl alcohol extract * 2 1.0
(9) Histidine * 3 0.1
* 1 Eisai products
* 2 Manufactured in Reference Example 1
* 3 Kyowa Hakko
[0086]
(Production method)
A. A part of components (5), (6) and (7) are mixed by heating and kept at 75 ° C.
B. Components (1) to (4) are mixed by heating and kept at 75 ° C.
C. Add A slowly to B.
D. While cooling C, (8) and (9) dissolved in the rest of (7) were added to obtain an ointment.
[0087]
Embodiment 8 FIG. ointment
(Ingredient) (%)
(1) Stearic acid 18.0
(2) Cetanol 4.0
(3) Preservative appropriate amount
(4) Triethanolamine 2.0
(5) Glycerin 5.0
(6) Remaining amount of purified water
(7) Cattleya Labata
Ethyl alcohol extract * 1 1.0
(8) Orgonum extract * 2 0.3
(9) Sodium pyrrolidonecarboxylate * 3 0.3
* 1 Manufactured in Reference Example 1
* 2 Maruzen Pharmaceutical Co., Ltd.
* 3 Made by Ajinomoto Co.
[0088]
(Production method)
A. A part of components (4), (5) and (6) are mixed by heating and kept at 75 ° C.
B. Heat and mix components (1)-(3) and maintain at 75 ° C.
C. Add A slowly to B.
D. While cooling C, (7) to (9) dissolved in the rest of (6) were added to obtain an ointment.
[0089]
Examples 7 and 8 are excellent in stability over time, and can be applied to the skin to prevent "dullness", spots and freckles on the skin, and to make the skin beautiful and transparent, and to improve skin glue and gloss. It was an ointment capable of preventing skin aging.
[0090]
Example 9 Serum (%)
(1) Polyoxyethylene isostearate (50) hydrogenated castor oil 0.2
(2) Hydrogenated soybean phospholipid 0.3
(3) Glycerin 7.0
(4) dl-α-tocopherol * 1 0.3
(5) Licorice extract * 2 0.2
(6) Cholesterol 0.1
(7) Ethyl alcohol 6.0
(8) Sodium hydroxymethoxybenzophenone sulfonate * 3 0.2
(9) L-ascorbic acid disodium sulfate 0.5
(10) Citric acid 0.01
(11) Sodium citrate 0.1
(12) Xanthan gum 0.1
(13) Methyl cellulose 0.1
(14) Black tea extract * 4 0.1
(15) Kokahi extract * 5 0.1
(16) Beech bud extract * 6 0.1
(17) Peony extract * 7 0.1
(18) Nicotinamide * 8 0.05
(19) Oat extract * 9 0.1
(20) Tomato extract * 10 0.1
(21) Oat extract * 11 0.1
(22) Preservative appropriate amount
(23) Suitable amount of fragrance
(24) Cattleya violacea (C. violacea)
Ethyl alcohol extract * 12 1.0
(25) Remaining purified water
* 1 Eisai products
* 2 Maruzen Pharmaceutical Co., Ltd.
* 3 Shonan Chemical Industries
* 4 Maruzen Pharmaceutical Co., Ltd.
* 5 Maruzen Pharmaceutical Co., Ltd.
* 6 GATEFOSSE
* 7 Made by Inabata Inc.
* 8 Wako Pure Chemical Industries
* 9 Maruzen Pharmaceutical Co., Ltd.
* 10 Made by Esperis
* 11 Maruzen Pharmaceutical Co., Ltd.
* 12 Manufactured in Reference Example 1
[0091]
(Production method)
A. Components (1) to (7) are mixed and dissolved.
B. (8) to (13) and (25) are heated and mixed, and cooled to room temperature.
C. A and (14) to (24) were added to B and mixed to obtain a serum.
[0092]
Example 9 is excellent in stability over time, and can be applied to the skin to prevent the skin from "dullness", spots and freckles, and to provide a beautiful skin with a transparent feeling. It was a serum that was extremely effective in preventing aging.
[0093]
Embodiment 10 FIG. pack
(Ingredient) (%)
(1) Polyvinyl alcohol 15.0
(2) Silicic anhydride 0.5
(3) Polyethylene glycol 0.5
(4) Polyoxypropylene methyl glucoside 5.0
(5) Glycerin 5.0
(6) Remaining amount of purified water
(7) dipotassium glycyrrhizinate * 1 0.1
(8) Ethyl alcohol 10.0
(9) Preservative appropriate amount
(10) Cattleya violasea (C. violacea) purified water extract * 2 0.1
(11) Cattleya elongata (C. elongata)
Ethyl alcohol extract * 2 0.2
(12) Ginkgo extract * 3 0.2
(13) Arnica extract * 4 0.2
(14) Green tea extract * 5 0.2
(15) Suitable amount of fragrance
* 1 Maruzen Pharmaceutical Co., Ltd.
* 2 Manufactured in Reference Example 1
* 3 Tokiwa Plant Chemical Laboratory
* 4 Maruzen Pharmaceutical Co., Ltd.
* 5 Maruzen Pharmaceutical Co., Ltd.
[0094]
(Production method)
A. Components (1) to (7) are mixed and heated to 70 ° C. to dissolve.
B. Mix and dissolve components (8) and (9).
C. B was added to the above A, mixed, cooled, and the components (10) to (15) were uniformly dispersed to obtain a pack.
[0095]
Embodiment 11 FIG. pack
(Ingredient) (%)
(1) Polyvinyl alcohol 15.0
(2) Kaolin 2.0
(3) Titanium oxide 2.0
(4) Polyethylene glycol 0.5
(5) Polyoxypropylene methyl glucoside 3.0
(6) Glycerin 10.0
(7) Remaining amount of purified water
(8) Ethyl alcohol 20.0
(9) Preservative appropriate amount
(10) Rosemary water * 1 10.0
(11) of Leria purpurata
50 vol% aqueous ethyl alcohol extract * 2 0.2
(12) Soybean extract * 3 0.5
(13) Wheat extract * 4 0.5
(14) Button extract * 5 0.5
(15) Jujube extract * 6 0.5
(16) Suitable amount of fragrance
* 1 Maruzen Pharmaceutical Co., Ltd.
* 2 Manufactured in Reference Example 1
* 3 Maruzen Pharmaceutical Co., Ltd.
* 4 Seiwa Kasei Co., Ltd.
* 5 Made by Ichimaru Falcos
* 6 Maruzen Pharmaceutical Co., Ltd.
[0096]
(Production method)
A. Components (1) to (7) are mixed and heated to 70 ° C. to dissolve.
B. Components (8) and (9) are mixed and dissolved.
C. B was added to the above A, mixed, cooled, and the components (10) to (16) were uniformly dispersed to obtain a pack.
[0097]
Examples 10 and 11 are excellent in stability over time, and can be applied to the skin to prevent "dullness" and spots on the skin, and to make the skin beautiful and transparent. It was a pack to prevent aging.
[0098]
Embodiment 12 FIG. Liquid Foundation:
(Ingredient) (%)
(1) Dipentaerythritol fatty acid ester 2.0
(2) Liquid paraffin 5.0
(3) Stearic acid 2.0
(4) Cetanol 1.0
(5) Self-emulsifying glyceryl monostearate 1.0
(6) 2-ethylhexyl paramethoxycinnamate 8.0
(7) Retinol palmitate * 1 0.5
(8) Acetic acid-dl-α-tocopherol * 2 0.2
(9) Preservative appropriate amount
(10) Glycerin 5.0
(11) Triethanolamine 1.0
(12) Carboxymethyl cellulose 0.2
(13) Bentonite 0.5
(14) Remaining amount of purified water
(15) Titanium oxide 6.0
(16) Fine particle titanium oxide 2.0
(17) Fine particle zinc oxide 5.0
(18) Mica 2.0
(19) Talc 4.0
(20) Color pigment 4.0
(21) Cattleya Labata (C. labiata)
50 vol% aqueous ethyl alcohol extract * 3 0.01
(22) Mannitol * 4 0.1
(23) Nicotinamide * 5 0.5
(24) Licorice extract * 6 0.1
(25) Kiwi extract * 7 0.1
(26) Coffee extract * 8 0.1
(27) Suitable amount of fragrance
* 1 manufactured by Roche Japan
* 2 Eisai products
* 3 Manufactured in Reference Example 1
* 4 Wako Pure Chemical Industries
* 5 Sigma
* 6 Maruzen Pharmaceutical Co., Ltd.
* 7 Made by Ichimaru Falcos
* 8 Made by Ichimaru Falcos
[0099]
(Production method)
A. The components (1) to (9) are heated and mixed and dissolved.
B. Add components (15) to (20) to A, mix uniformly, and keep at 70 ° C.
C. Components (10) to (14), (22) and (23) are uniformly dissolved and kept at 70 ° C.
D. Add B to C and emulsify uniformly.
E. FIG. After cooling D, components (21) and (24) to (27) were added to obtain a liquid foundation.
[0100]
Embodiment 13 FIG. Liquid Foundation:
(Ingredient) (%)
(1) Dipentaerythritol fatty acid ester 2.0
(2) Liquid paraffin 5.0
(3) Stearic acid 2.0
(4) Cetanol 1.0
(5) Self-emulsifying glyceryl monostearate 1.0
(6) 2-ethylhexyl paramethoxycinnamate 8.0
(7) 4-tert-butyl-4 ′
-Methoxydibenzoylmethane 2.0
(8) Stearyl glycyrrhetinate * 1 0.2
(9) Preservative appropriate amount
(10) Glycerin 5.0
(11) Triethanolamine 1.0
(12) Carboxymethyl cellulose 0.2
(13) Bentonite 0.5
(14) Remaining amount of purified water
(15) Titanium oxide 6.0
(16) Fine particle titanium oxide 2.0
(17) Fine particle zinc oxide 5.0
(18) Mica 2.0
(19) Talc 4.0
(20) Color pigment 4.0
(21) Cattleya elongata (C. elongata)
Ethyl alcohol extract * 2 0.2
(22) White lily extract * 3 0.1
(24) Hop extract * 4 0.1
(25) chamomile extract * 5 0.1
(26) Aloe extract * 6 0.1
(27) Suitable amount of fragrance
* 1 manufactured by Roche Japan
* 2 Manufactured in Reference Example 1
* 3 Nikko Chemicals
* 4 Maruzen Pharmaceutical Co., Ltd.
* 5 Made by Koei Kogyo Co., Ltd.
* 6 Maruzen Pharmaceutical Co., Ltd.
[0101]
(Production method)
A. Components (1) to (9) are mixed and dissolved.
B. Add components (15) to (20) to A, mix uniformly, and keep at 70 ° C.
C. Components (10) to (14) are uniformly dissolved and kept at 70 ° C.
D. Add B to C and emulsify uniformly.
E. FIG. After cooling D, components (21) to (27) were added to obtain a liquid foundation.
[0102]
Embodiment 14 FIG. Sunscreen latex
(Ingredient) (%)
(1) Polyoxyalkylene-modified organopolysiloxane 1.0
(2) Dimethyl polysiloxane 5.0
(3) Octamethylcyclotetrasiloxane 20.0
(4) Isotridecyl isononanoate 5.0
(5) 2-Ethylhexyl paramethoxycinnamate 5.0
(6) β-carotene * 1 0.001
(7) Safflower oil * 2 0.5
(8) Preservative appropriate amount
(9) Suitable amount of fragrance
(10) Fine particle titanium oxide 3.0
(11) Fine particle zinc oxide 12.0
(12) Polystyrene powder 3.0
(13) Trimethylsiloxysilicic acid 0.5
(14) Dipropylene glycol 3.0
(15) Ethyl alcohol 10.0
(16) Remaining amount of purified water
(17) Salt 0.2
(18) Mannitol * 3 0.05
(19) Purified water extract of Cattleya violacea (C. violacea) * 4 2.0
(20) Lavender water * 5 5.0
(21) Orange flower water * 6 5.0
(22) Cucumber extract * 7 0.5
(23) Altea extract * 8 0.5
(24) Nettle extract * 9 0.5
(25) Soybean extract * 10 0.5
* 1 Sankyo Pharmaceutical Co., Ltd.
* 2 Made by Nisshin Oil Refinery
* 3 Wako Pure Chemical Industries
* 4 Manufactured in Reference Example 1
* 5 Maruzen Pharmaceutical Co., Ltd.
* 6 Made by Koei Kogyo Co., Ltd.
* 7 Made by Ichimaru Falcos
* 8 Koei Kogyo Co., Ltd.
* 9 Maruzen Pharmaceutical Co., Ltd.
* 10 Made by Ichimaru Falcos
[0103]
(Production method)
A. Components (1) to (13) are mixed and dissolved.
B. Components (14) to (18) are mixed and dissolved.
C. Add B to A and emulsify uniformly.
D. The ingredients (19) to (25) were added to C to obtain a sunscreen emulsion.
[0104]
Embodiment 15 FIG. Sunscreen latex
(Ingredient) (%)
(1) Polyoxyalkylene-modified organopolysiloxane 1.0
(2) Dimethyl polysiloxane 5.0
(3) Octamethylcyclotetrasiloxane 20.0
(4) Isotridecyl isononanoate 5.0
(5) 2-Ethylhexyl paramethoxycinnamate 8.0
(6) 4-tert-butyl-4 ′
-Methoxydibenzoylmethane 2.0
(7) Preservative appropriate amount
(8) Suitable amount of fragrance
(9) Silicon-treated fine particle titanium oxide 8.0
(10) Silicon-treated fine particle zinc oxide 7.0
(11) Polystyrene powder 3.0
(12) Trimethylsiloxysilicic acid 0.5
(13) Dipropylene glycol 3.0
(14) Ethyl alcohol 10.0
(15) Remaining amount of purified water
(16) Salt 0.2
(17) of Leria purpurata
50 vol% aqueous ethyl alcohol extract * 1 1.0
(18) Magnesium phosphate-L-ascorbyl * 2 3.0
(19) Oolong tea extract * 3 0.1
(20) mallow extract * 4 1.0
(21) Coltsfoot extract * 5 0.1
(22) Hawthorn extract * 6 0.1
(23) Rosemary extract * 7 0.1
* 1 Manufactured in Reference Example 1
* 2 Nikko Chemicals
* 3 Made by Ichimaru Falcos
* 4 A. M. I company
* 5 Maruzen Pharmaceutical Co., Ltd.
* 6 Maruzen Pharmaceutical Co., Ltd.
* 7 Maruzen Pharmaceutical Co., Ltd.
[0105]
(Production method)
A. The components (1) to (12) are mixed and dissolved.
B. Components (13) to (16) and (18) are mixed and dissolved.
C. Add B to A and emulsify uniformly.
D. The ingredients (17) and (19) to (23) were added to C to obtain a sunscreen emulsion.
[0106]
Examples 12 to 16 are excellent in stability over time and, when applied to the skin, are excellent in the effect of preventing skin darkening and spots and freckles due to sunburn, etc., suppress dullness and roughness of skin, and prevent skin aging. It was a liquid foundation and a sunscreen milky lotion which was excellent in the effect.
[0107]
【The invention's effect】
As described above, the external preparation for skin containing the plant extract of cattleyas of the present invention has an excellent melanin production inhibitory effect, exerts a high inhibitory effect on pigmentation, dull skin, sunburn, etc. It is effective in preventing and improving skin darkening, spots, freckles, etc., due to the formation of lipid peroxides, inflammation, blackening, aging, etc. due to the production of active oxygen in the skin. It has improvement and prevention effects. In addition, the external preparation for skin of the present invention, which is prepared by combining the plant extract of cattleyas of the present invention with other medicinal agents such as a whitening agent, an antioxidant, an anti-inflammatory agent, a cell activator, and an ultraviolet ray inhibitor, And synergistically exhibit more excellent whitening and / or antioxidant effects as compared to the case where the plant extract of cattleyas and other medicinal agents are used alone.
Therefore, the external preparation for skin of the present invention can be advantageously used as cosmetics or pharmaceuticals for the purpose of whitening or aging.
Claims (4)
(A)ラン科カトレア属、ブラッソカトレア属、ブラッソレリオカトレア属、レリオカトレア属、レリオカトニア属、カトレイオプシス属、カトレイトニア属、レリア属に属する植物の一種又は二種以上から選ばれる抽出物
(B)美白剤、抗酸化剤、抗炎症剤、細胞賦活剤及び紫外線防止剤から選ばれる薬効剤の一種又は二種以上を含有することを特徴とする皮膚外用剤。The following components (A) and (B)
(A) an extract selected from one or more of plants belonging to the orchidaceae genus Cattleya, Brassocatrea, Brassoleliocatrea, Leriocatrea, Leriocatonia, Catreiopsis, Catretonia, Leria; (B) whitening agent An external preparation for skin, characterized by containing one or more kinds of medicinal agents selected from antioxidants, anti-inflammatory agents, cell activators and UV inhibitors.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002226754A JP2004067549A (en) | 2002-08-02 | 2002-08-02 | External preparation for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002226754A JP2004067549A (en) | 2002-08-02 | 2002-08-02 | External preparation for skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2004067549A true JP2004067549A (en) | 2004-03-04 |
Family
ID=32013984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002226754A Pending JP2004067549A (en) | 2002-08-02 | 2002-08-02 | External preparation for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2004067549A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006176440A (en) * | 2004-12-22 | 2006-07-06 | Kinjirushi Kk | Bleaching or aging-preventing agent composition for skin and cosmetic |
| JP2006282537A (en) * | 2005-03-31 | 2006-10-19 | Kose Corp | Cell-activating agent, and external preparation for skin, using the same |
| FR2928549A1 (en) * | 2008-03-13 | 2009-09-18 | Lvmh Rech | USE OF AN EXTRACT OF BRASSOCATTLEYA MARCELLA KOSS ORCHIDEE AS AN AGENT TO PREVENT OR DELAY THE APPEARANCE OF SIGNS OF SKIN AGING |
| FR2928547A1 (en) * | 2008-03-13 | 2009-09-18 | Lvmh Rech | EXTRACT OF BRASSOCATTLE MARCELLA KOSS ORCHID AND USE THEREOF AS SKIN DEPIGMENTING AGENT |
| WO2009139231A1 (en) | 2008-05-16 | 2009-11-19 | 株式会社ニチレイバイオサイエンス | Extract produced from orchid family plant, method for production thereof, and preparation for external application to skin comprising extract produced from orchid family plant |
| JP2015155394A (en) * | 2014-02-21 | 2015-08-27 | 佐藤製薬株式会社 | photoaging inhibitor |
| JP2017014202A (en) * | 2015-06-30 | 2017-01-19 | 株式会社コーセー | Cosmetic |
-
2002
- 2002-08-02 JP JP2002226754A patent/JP2004067549A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006176440A (en) * | 2004-12-22 | 2006-07-06 | Kinjirushi Kk | Bleaching or aging-preventing agent composition for skin and cosmetic |
| JP2006282537A (en) * | 2005-03-31 | 2006-10-19 | Kose Corp | Cell-activating agent, and external preparation for skin, using the same |
| US8293287B2 (en) | 2008-03-13 | 2012-10-23 | L V M H Recherche | Use of a Brassocattleya marcella Koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging |
| FR2928547A1 (en) * | 2008-03-13 | 2009-09-18 | Lvmh Rech | EXTRACT OF BRASSOCATTLE MARCELLA KOSS ORCHID AND USE THEREOF AS SKIN DEPIGMENTING AGENT |
| JP2009221201A (en) * | 2008-03-13 | 2009-10-01 | Lvmh Recherche | Use of orchid extract from brassocattleya marcella koss as active agent for preventing or delaying appearance of skin aging symptom |
| JP2009221200A (en) * | 2008-03-13 | 2009-10-01 | Lvmh Recherche | Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation agent |
| DE102009012270A1 (en) | 2008-03-13 | 2009-11-26 | L V M H Recherche (Gie) | Brassocattleya Marcella Koss Orchid extract and its use as a skin depigmenting agent |
| DE102009012271A1 (en) | 2008-03-13 | 2009-12-03 | L V M H Recherche (Gie) | Use of a Brassocattleya marcella Koss orchid extract as an active ingredient to prevent or delay the onset of signs of aging |
| FR2928549A1 (en) * | 2008-03-13 | 2009-09-18 | Lvmh Rech | USE OF AN EXTRACT OF BRASSOCATTLEYA MARCELLA KOSS ORCHIDEE AS AN AGENT TO PREVENT OR DELAY THE APPEARANCE OF SIGNS OF SKIN AGING |
| US8414933B2 (en) | 2008-03-13 | 2013-04-09 | L V M H Recherche | Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation agent |
| WO2009139231A1 (en) | 2008-05-16 | 2009-11-19 | 株式会社ニチレイバイオサイエンス | Extract produced from orchid family plant, method for production thereof, and preparation for external application to skin comprising extract produced from orchid family plant |
| JP2015155394A (en) * | 2014-02-21 | 2015-08-27 | 佐藤製薬株式会社 | photoaging inhibitor |
| JP2017014202A (en) * | 2015-06-30 | 2017-01-19 | 株式会社コーセー | Cosmetic |
| JP7075177B2 (en) | 2015-06-30 | 2022-05-25 | 株式会社コーセー | Cosmetics |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005220084A (en) | Acerola seed extract-containing composition | |
| JP5571280B2 (en) | Sebum production promoter | |
| WO2004041236A1 (en) | Composition for preparation for external use on skin and method of using the same | |
| JP3987793B2 (en) | Topical skin preparation | |
| JP2003063925A (en) | Skin care preparation | |
| JP2004238394A (en) | Rebound inhibitor and skin care preparation for external use containing the same | |
| JP2002212087A (en) | External preparation for skin | |
| JP2004010526A (en) | External preparation for skin | |
| JP2004196669A (en) | Melanocyte proliferation inhibitor and skin care preparation for external use comprising the same | |
| JP6781529B2 (en) | Skin care cosmetic composition | |
| JP4203325B2 (en) | Skin external preparation and skin external preparation composition | |
| JP2002265313A (en) | Skin care preparation | |
| JP2002332224A (en) | Anti-ageing skin care preparation and anti-ageing skin care preparation composition | |
| JP2002138027A (en) | External preparation for skin | |
| JP2004051492A (en) | Antiaging agent or cell activator and external preparation for skin comprising the same | |
| JP2002275081A (en) | Skin care preparation | |
| JP2003160463A (en) | External preparation for skin | |
| JP3754646B2 (en) | Topical skin preparation | |
| JP2003252742A (en) | Melanocyte dendrite formation inhibitor and skin care preparation containing the same | |
| JP2004067549A (en) | External preparation for skin | |
| JP2007210915A (en) | Skin preparation for external use | |
| JP2004137233A (en) | Antiaging agent and external preparation for skin using the same | |
| JP4713032B2 (en) | Skin preparation | |
| JP3895636B2 (en) | Anti-aging agent and external preparation for skin using the same | |
| JP2005089427A (en) | Skin care preparation for external use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041222 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20041222 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050617 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050622 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20051019 |